Plant polyphenol oxidase homologs

ABSTRACT

This invention relates to an isolated nucleic acid fragment encoding a polyphenol oxidase enzyme. The invention also relates to the construction of a chimeric gene encoding all or a portion of the polyphenol oxidase enzyme, in sense or antisense orientation, wherein expression of the chimeric gene results in production of altered levels of the polyphenol oxidase enzyme in a transformed host cell.

This application claims the benefit of U.S. Provisional Application No. 60/119,590, filed Feb. 10, 1999.

FIELD OF THE INVENTION

This invention is in the field of plant molecular biology. More specifically, this invention pertains to nucleic acid fragments encoding polyphenol oxidase enzymes in plants and seeds.

BACKGROUND OF THE INVENTION

Polyphenol oxidase (PPO) catalyzes the oxidation of mono- and O-diphenols to O-diquinones. The oxidation of mono- and diphenols, which occurs during fruit ripening and plant wounding, produces and undesirable browning of fruit and vegetable material (Hunt M. D., et al. 1993, Plant Mol. Biol. 21(1):59-68). Inhibition of polyphenol oxidase activity would likely prevent the accumulation of the brown discoloration in fruits and may improve flavor. Furthermore, polyphenols function as antioxidants; inhibition of polyphenol oxidase would increase the level of polyphenols in fruits and vegetables and thus add food value.

In plants polyphenol oxidase activity appears to be encoded by a multigene family. For example, in tomato seven nuclear genes have been reported that encode PPO activity (Newman S. M., et al., 1993, Plant Mol. Biol. 21(6):1035-1051). The nucleic acid fragments described herein also appear to encode several different PPO enzymes. Based on amino acid homology, seven different PPO types (that share less than 75% similarity at the amino acid level) have been identified in soybean cDNA libraries. Nucleic acid fragments encoding a two types of PPO enzymes from corn and one type of PPO from wheat are also described. The various types of PPO enzymes have been designated A-I.

There is a great deal of interest in identifying the genes that encode proteins involved in polyphenol oxidation in plants. These genes may be used in plant cells to control the oxidation of phenolic compounds that impart discoloration to fruit and vegetables. The genes may also be used to increase the level of antioxidants in fruits and vegetables. Accordingly, the availability of nucleic acid sequences encoding all or a portion of a PPO enzyme would facilitate studies to better understand polyphenol oxidation in plants and provide genetic tools to inhibit or otherwise alter PPO activity which in turn could provide mechanisms to control discoloration in fruits and vegetables and increase the pool of antioxidant compounds in plant cells.

SUMMARY OF THE INVENTION

The present invention relates to isolated polynucleotides comprising a nucleotide sequence encoding a polypeptide of at least 112 amino acids that has at least 80% identity based on the Clustal method of alignment when compared to a polypeptide selected from the group consisting of corn polyphenol oxidase polypeptides of SEQ ID NOs:4, 38 and 42, soybean polyphenol oxidase polypeptides of SEQ ID NOs:6, 24 28, 32, 34, 36 and 44, and a wheat polyphenol oxidase polypeptide of SEQ ID NO: 14. The present invention also relates to an isolated polynucleotide comprising the complement of the nucleotide sequences described above.

The present invention also relates to isolated polynucleotides comprising a nucleotide sequence encoding a polypeptide of at least 163 amino acids that has at least 80% identity based on the Clustal method of alignment when compared to a polypeptide selected from the group consisting of a corn polyphenol oxidase polypeptide of SEQ ID NO:40, and soybean polyphenol oxidase polypeptides of SEQ ID NOs:10 and 20. The present invention also relates to an isolated polynucleotide comprising the complement of the nucleotide sequences described above.

The present invention also relates to isolated polynucleotides comprising a nucleotide sequence encoding a polypeptide of at least 50 amino acids that has at least 80% identity based on the Clustal method of alignment when compared to a polypeptide selected from the group consisting of SEQ ID NOs:2, 8, 12, 16, 18, 22, 30 and 46.

It is preferred that the isolated polynucleotides of the claimed invention consists of a nucleic acid sequence selected from the group consisting of SEQ ID NOs:1, 3, 5, 7, 9, 11, 13,15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43 and 45 that codes for the polypeptide selected from the group consisting of SEQ ID NOs:2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, 34, 36, 38, 40, 42, 44 and 46. The present invention also relates to an isolated polynucleotide comprising a nucleotide sequences of at least one of 40 (preferably at least one of 30, most preferably at least one of 15) contiguous nucleotides derived from a nucleotide sequence selected from the group consisting of SEQ ID NOs:3, 5, 9, 13, 19, 23, 27, 31, 33, 35, 37, 39, 41, and 43 and the complement of such nucleotide sequences.

The present invention relates to a chimeric gene comprising an isolated polynucleotide of the present invention operably linked to suitable regulatory sequences.

The present invention relates to an isolated host cell comprising a chimeric gene of the present invention or an isolated polynucleotide of the present invention. The host cell may be eukaryotic, such as a yeast or a plant cell, or prokaryotic, such as a bacterial cell. The present invention also relates to a virus, preferably a baculovirus, comprising an isolated polynucleotide of the present invention or a chimeric gene of the present invention.

The present invention relates to a process for producing an isolated host cell comprising a chimeric gene of the present invention or an isolated polynucleotide of the present invention, the process comprising either transforming or transfecting an isolated compatible host cell with a chimeric gene or isolated polynucleotide of the present invention.

The present invention relates to a polyphenol oxidase polypeptide of at least 112 amino acids comprising at least 80% homology based on the Clustal method of alignment compared to a polypeptide selected from the group consisting of SEQ ID NOs:4, 6, 14, 24, 32, 34, 36, 38, 42 and 44.

The present invention relates to a polyphenol oxidase polypeptide of at least 163 amino acids comprising at least 80% homology based on the Clustal method of alignment compared to a polypeptide selected from the group consisting of SEQ ID NOs:10, 20 and 40.

The present invention also relates to a polypeptide of at least 50 amino acids comprising at least 80% homology based on the Clustal method of alignment compared to a polypeptide selected from the group consisting of SEQ ID NOs:2, 8, 12, 16, 18, 22, 30 and 46.

The present invention relates to a method of selecting an isolated polynucleotide that affects the level of expression of a polyphenol oxidase polypeptide in a host cell, preferably a plant cell, the method comprising the steps of: (a) constructing an isolated polynucleotide of the present invention or an isolated chimeric gene of the present invention; (b) introducing the isolated polynucleotide or the isolated chimeric gene into a host cell; (c) measuring the level a polyphenol oxidase polypeptide in the host cell containing the isolated polynucleotide; and (d) comparing the level of a polyphenol oxidase polypeptide in the host cell containing the isolated polynucleotide with the level of a polyphenol oxidase polypeptide in the host cell that does not contain the isolated polynucleotide.

The present invention relates to a method of obtaining a nucleic acid fragment encoding a substantial portion of a polyphenol oxidase polypeptide gene, preferably a plant polyphenol oxidase polypeptide gene, comprising the steps of: synthesizing an oligonucleotide primer comprising a nucleotide sequence of at least one of 60 (preferably at least one of 40, most preferably at least one of 30) contiguous nucleotides derived from a nucleotide sequence selected from the group consisting of SEQ ID NOs:3, 5, 9, 13, 19, 23, 27, 31, 33, 35, 37, 39, 41, and 43 and the complement of such nucleotide sequences; and amplifying a nucleic acid fragment (preferably a cDNA inserted in a cloning vector) using the oligonucleotide primer. The amplified nucleic acid fragment preferably will encode a portion of a polyphenol oxidase amino acid sequence.

The present invention also relates to a method of obtaining a nucleic acid fragment encoding all or a substantial portion of the amino acid sequence encoding a polyphenol oxidase polypeptide comprising the steps of: probing a cDNA or genomic library with an isolated polynucleotide of the present invention; identifying a DNA clone that hybridizes with an isolated polynucleotide of the present invention; isolating the identified DNA clone; and sequencing the cDNA or genomic fragment that comprises the isolated DNA clone.

The present invention relates to a composition, such as a hybridization mixture, comprising an isolated polynucleotide of the present invention.

The present invention relates to an isolated polynucleotide of the present invention comprising at least one of 30 contiguous nucleotides derived from a nucleic acid sequence selected from the group consisting of SEQ ID NOs:1, 3, 5, 7, 9, 11, 13, 15, 17, 19. 21, 23, 25, 27, 19, 31, 33, 35, 37, 39, 41, 43 and45.

The present invention relates to an expression cassette comprising an isolated polynucleotide of the present invention operably linked to a promoter.

The present invention relates to a method for positive selection of a transformed cell comprising: (a) transforming a host cell with the chimeric gene of the present invention or an expression cassette of the present invention; and (b) growing the transformed host cell, preferably plant cell, such as a monocot or a dicot, under conditions which allow expression of the polyphenol oxidase polynucleotide in an amount sufficient to complement a null mutant to provide a positive selection means. Inhibition of polyphenol oxidase activity would likely prevent the accumulation of the brown discoloration in fruits and may improve flavor.

BRIEF DESCRIPTION OF THE SEQUENCE DESCRIPTIONS

The invention can be more fully understood from the following detailed description and the accompanying Sequence Listing which form a part of this application.

Table 1 lists the polypeptides that are described herein, the designation of the cDNA clones that comprise the nucleic acid fragments encoding polypeptides representing all or a substantial portion of these polypeptides, and the corresponding identifier (SEQ ID NO:) as used in the attached Sequence Listing. Table 1 also identifies the cDNA clones as individual ESTs (“EST”), the sequences of the entire cDNA inserts comprising the indicated cDNA clones (“FIS”), contigs assembled from two or more ESTs (“Contig”), contigs assembled from an FIS and one or more ESTs (“Contig*”), or sequences encoding the entire protein derived from an FIS, a contig, or an FIS and PCR (“CGS”). Nucleotide sequences, SEQ ID NOs:3, 9, 13, 19, 27, 31, 33 and amino acid sequences SEQ ID NOs:4, 10, 14, 20, 28, 32 and 34 were determined by further sequence analysis of cDNA clones encoding the amino acid sequences set forth in SEQ ID NOs:2, 8, 12, 16, 18, 22, 26, 30 and 46. Nucleotide SEQ ID NOs:1, 7, 11, 15, 17, 21, 25, 29 and 45 and amino acid SEQ ID NOs:2, 8, 12, 16, 18, 22, 26, 30 and 46 were presented in a U.S. Provisional Application No. 60/119,590, filed Feb. 10, 1999. The sequence descriptions and Sequence Listing attached hereto comply with the rules governing nucleotide and/or amino acid sequence disclosures in patent applications as set forth in 37 C.F.R. §1.821-1.825.

TABLE I Polyphenol Oxidase Enzymes SEQ ID NO: (Nucleo- (Amino Protein Clone Designation tide) Acid) Polyphenol Oxidase A cpi1c.pk001.o22 EST  1  2 Polyphenol Oxidase A cpi1c.pk001.o22 FIS  3  4 Polyphenol Oxidase A Contig Composed of:  5  6 p0083.cldcl92r p0107.cbcau93r Polyphenol Oxidase A Contig composed of:  7  8 sfl1.pk0041.a9 sfl1.pk0111.b7 sfl1.pk0122.h9 Polyphenol Oxidase A sfl1.pk0111.b7 CGS  9 10 Polyphenol Oxidase A wlm96.pk0023.a11 EST 11 12 Polyphenol Oxidase A wlm96.pk0023.a11 CGS 13 14 Polyphenol Oxidase B Contig composed of: 15 16 sfl1.pk0074.f6 sfl1.pk132.d21 Polyphenol Oxidase B Contig composed of: 17 18 sfl1.pk0025.b4 sfl1.pk0095.h1 sfl1.pk133.k3 srr3c.pk003.d19 Polyphenol Oxidase B sfl1.pk133.k3 CGS 19 20 Polyphenol Oxidase B Contig composed of: 21 22 sgc7c.pk001.i6 sgc7c.pk001.o2 Polyphenol Oxidase C Contig composed of: 23 24 sgc6c.pk001.h11 sgc6c.pk001.h13 Polyphenol Oxidase D Contig composed of: 25 26 sls1c.pk001.i11 sls1c.pk003.l12 sls2c.pk001.e2 Polyphenol Oxidase D sls1c.pk001.i11 CGS 27 28 Polyphenol Oxidase E Contig composed of: 29 30 sfl1.pk0057.e9 sfl1.pk0099.a3 sgs4c.pk002.n13 src3c.pk005.d9 srr1c.pk002.j24 Polyphenol Oxidase E src3c.pk005.d9 CGS 31 32 Polyphenol Oxidase F sfl1.pk126.m8 CGS 33 34 Polyphenol Oxidase G sfl1.pk0007.c3 CGS 35 36 Polyphenol Oxidase H Contig composed of: 37 38 ccs1c.pk002.k13 p0013.csdlu31rb p0013.csdlu31rd p0117.chclp75r Polyphenol Oxidase H Contig composed of: 39 40 csc1c.pk004.a22 csiln.pk0036.d5 p0016.ctsbd45rc p0016.ctsbd45rf p0016.ctsbw54rb p0018.chssz59rb p0119.cmtnp57r Polyphenol Oxidase H p0097.cqraa41r EST 41 42 Polyphenol Oxidase I sr1.pk0024.h11 EST 43 44 Polyphenol Oxidase F sfl1.pk126.m8 EST 45 46

The Sequence Listing contains the one letter code for nucleotide sequence characters and the three letter codes for amino acids as defined in conformity with the IUPAC-IUBMB standards described in Nucleic Acids Res. 13:3021-3030 (1985) and in the Biochemical J. 219 (No. 2):345-373 (1984) which are herein incorporated by reference. The symbols and format used for nucleotide and amino acid sequence data comply with the rules set forth in 37 C.F.R. §1.822.

DETAILED DESCRIPTION OF THE INVENTION

In the context of this disclosure, a number of terms shall be utilized. As used herein, a “polynucleotide” is a nucleotide sequence such as a nucleic acid fragment. A polynucleotide may be a polymer of RNA or DNA that is single- or double-stranded, that optionally contains synthetic, non-natural or altered nucleotide bases. A polynucleotide in the form of a polymer of DNA may be comprised of one or more segments of cDNA, genomic DNA, synthetic DNA, or mixtures thereof. An isolated polynucleotide of the present invention may include at least one of 60 contiguous nucleotides, preferably at least one of 40 contiguous nucleotides, most preferably one of at least 30 contiguous nucleotides derived from SEQ ID NOs:1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45 or the complement of such sequences.

As used herein, “contig” refers to a nucleotide sequence that is assembled from two or more constituent nucleotide sequences that share common or overlapping regions of sequence homology. For example, the nucleotide sequences of two or more nucleic acid fragments can be compared and aligned in order to identify common or overlapping sequences. Where common or overlapping sequences exist between two or more nucleic acid fragments, the sequences (and thus their corresponding nucleic acid fragments) can be assembled into a single contiguous nucleotide sequence.

As used herein. “substantially similar” refers to nucleic acid fragments wherein changes in one or more nucleotide bases results in substitution of one or more amino acids, but do not affect the functional properties of the polypeptide encoded by the nucleotide sequence. “Substantially similar” also refers to nucleic acid fragments wherein changes in one or more nucleotide bases does not affect the ability of the nucleic acid fragment to mediate alteration of gene expression by gene silencing through for example antisense or co-suppression technology. “Substantially similar” also refers to modifications of the nucleic acid fragments of the instant invention such as deletion or insertion of one or more nucleotides that do not substantially affect the functional properties of the resulting transcript vis-à-vis the ability to mediate gene silencing or alteration of the functional properties of the resulting protein molecule. It is therefore understood that the invention encompasses more than the specific exemplary nucleotide or amino acid sequences and includes functional equivalents thereof.

Substantially similar nucleic acid fragments may be selected by screening nucleic acid fragments representing subfragments or modifications of the nucleic acid fragments of the instant invention, wherein one or more nucleotides are substituted, deleted and/or inserted, for their ability to affect the level of the polypeptide encoded by the unmodified nucleic acid fragment in a plant or plant cell. For example, a substantially similar nucleic acid fragment representing at least one of 30 contiguous nucleotides derived from the instant nucleic acid fragment can be constructed and introduced into a plant or plant cell. The level of the polypeptide encoded by the unmodified nucleic acid fragment present in a plant or plant cell exposed to the substantially similar nucleic fragment can then be compared to the level of the polypeptide in a plant or plant cell that is not exposed to the substantially similar nucleic acid fragment.

For example, it is well known in the art that antisense suppression and co-suppression of gene expression may be accomplished using nucleic acid fragments representing less than the entire coding region of a gene, and by nucleic acid fragments that do not share 100% sequence identity with the gene to be suppressed. Moreover, alterations in a nucleic acid fragment which result in the production of a chemically equivalent amino acid at a given site, but do not effect the functional properties of the encoded polypeptide, are well known in the art. Thus, a codon for the amino acid alanine, a hydrophobic amino acid, may be substituted by a codon encoding another less hydrophobic residue, such as glycine, or a more hydrophobic residue, such as valine, leucine, or isoleucine. Similarly, changes which result in substitution of one negatively charged residue for another, such as aspartic acid for glutamic acid, or one positively charged residue for another, such as lysine for arginine, can also be expected to produce a functionally equivalent product. Nucleotide changes which result in alteration of the N-terminal and C-terninal portions of the polypeptide molecule would also not be expected to alter the activity of the polypeptide. Each of the proposed modifications is well within the routine skill in the art, as is determination of retention of biological activity of the encoded products. Consequently, an isolated polynucleotide comprising a nucleotide sequence of at least one of 60 (preferably at least one of 40, most preferably at least one of 30) contiguous nucleotides derived from a nucleotide sequence selected from the group consisting of SEQ ID NOs:1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 19, 31, 33, 35, 37, 39, 41, 43, 45 and the complement of such nucleotide sequences may be used in methods of selecting an isolated polynucleotide that affects the expression of a polypeptide (polyphenol oxidase) in a host cell. A method of selecting an isolated polynucleotide that affects the level of expression of a polypeptide in a host cell (eukaryotic, such as plant or yeast, prokaryotic such as bacterial, or viral) may comprise the steps of: constructing an isolated polynucleotide of the present invention or an isolated chimeric gene of the present invention; introducing the isolated polynucleotide or the isolated chimeric gene into a host cell; measuring the level a polypeptide in the host cell containing the isolated polynucleotide; and comparing the level of a polypeptide in the host cell containing the isolated polynucleotide with the level of a polypeptide in a host cell that does not contain the isolated polynucleotide.

Moreover, substantially similar nucleic acid fragments may also be characterized by their ability to hybridize. Estimates of such homology are provided by either DNA-DNA or DNA-RNA hybridization under conditions of stringency as is well understood by those skilled in the art (Hames and Higgins, Eds. (1985) Nucleic Acid Hybridisation, IRL Press, Oxford, U.K.). Stringency conditions can be adjusted to screen for moderately similar fragments, such as homologous sequences from distantly related organisms, to highly similar fragments, such as genes that duplicate functional enzymes from closely related organisms. Post-hybridization washes determine stringency conditions. One set of preferred conditions uses a series of washes starting with 6×SSC, 0.5% SDS at room temperature for 15 min, then repeated with 2×SSC, 0.5% SDS at 45° C. for 30 min, and then repeated twice with 0.2×SSC, 0.5% SDS at 50° C. for 30 min. A more preferred set of stringent conditions uses higher temperatures in which the washes are identical to those above except for the temperature of the final two 30 min washes in 0.2×SSC, 0.5% SDS was increased to 60° C. Another preferred set of highly stringent conditions uses two final washes in 0.1×SSC, 0.1% SDS at 65° C.

Substantially similar nucleic acid fragments of the instant invention may also be characterized by the percent identity of the amino acid sequences that they encode to the amino acid sequences disclosed herein, as determined by algorithms commonly employed by those skilled in this art. Suitable nucleic acid fragments (isolated polynucleotides of the present invention) encode polypeptides that are at least about 70% identical, preferably at least about 80% identical to the amino acid sequences reported herein. Preferred nucleic acid fragments encode amino acid sequences that are about 85% identical to the amino acid sequences reported herein. More preferred nucleic acid fragments encode amino acid sequences that are at least about 90% identical to the amino acid sequences reported herein. Most preferred are nucleic acid fragments that encode amino acid sequences that are at least about 95% identical to the amino acid sequences reported herein. Suitable nucleic acid fragments not only have the above homologies but typically encode a polypeptide having at least 50 amino acids, preferably at least 100 amino acids, more preferably at least 150 amino acids, still more preferably at least 200 amino acids, and most preferably at least 250 amino acids. Sequence alignments and percent identity calculations were performed using the Megalign program of the LASERGENE bioinformatics computing suite (DNASTAR Inc., Madison, Wis.). Multiple alignment of the sequences was performed using the Clustal method of alignment (Higgins and Sharp (1989) CABIOS. 5:151-1 53) with the default parameters (GAP PENALTY=10, GAP LENGTH PENALTY=10). Default parameters for pairwise alignments using the Clustal method were KTUPLE 1, GAP PENALTY=3, WINDOW=5 and DIAGONALS SAVED=5.

A “substantial portion” of an amino acid or nucleotide sequence comprises an amino acid or a nucleotide sequence that is sufficient to afford putative identification of the protein or gene that the amino acid or nucleotide sequence comprises. Amino acid and nucleotide sequences can be evaluated either manually by one skilled in the art, or by using computer-based sequence comparison and identification tools that employ algorithms such as BLAST (Basic Local Alignment Search Tool; Altschul et al. (1993) J. Mol. Biol. 215:403-410). In general, a sequence of ten or more contiguous amino acids or thirty or more contiguous nucleotides is necessary in order to putatively identify a polypeptide or nucleic acid sequence as homologous to a known protein or gene. Moreover, with respect to nucleotide sequences, gene-specific oligonucleotide probes comprising 30 or more contiguous nucleotides may be used in sequence-dependent methods of gene identification (e.g., Southern hybridization) and isolation (e.g., in situ hybridization of bacterial colonies or bacteriophage plaques). In addition, short oligonucleotides of 12 or more nucleotides may be used as amplification primers in PCR in order to obtain a particular nucleic acid fragment comprising the primers. Accordingly, a “substantial portion” of a nucleotide sequence comprises a nucleotide sequence that will afford specific identification and/or isolation of a nucleic acid fragment comprising the sequence. The instant specification teaches amino acid and nucleotide sequences encoding polypeptides that comprise one or more particular plant proteins. The skilled artisan, having the benefit of the sequences as reported herein, may now use all or a substantial portion of the disclosed sequences for purposes known to those skilled in this art. Accordingly, the instant invention comprises the complete sequences as reported in the accompanying Sequence Listing, as well as substantial portions of those sequences as defined above.

“Codon degeneracy” refers to divergence in the genetic code permitting variation of the nucleotide sequence without effecting the amino acid sequence of an encoded polypeptide. Accordingly, the instant invention relates to any nucleic acid fragment comprising a nucleotide sequence that encodes all or a substantial portion of the amino acid sequences set forth herein. The skilled artisan is well aware of the “codon-bias” exhibited by a specific host cell in usage of nucleotide codons to specify a given amino acid. Therefore, when synthesizing a nucleic acid fragment for improved expression in a host cell, it is desirable to design the nucleic acid fragment such that its frequency of codon usage approaches the frequency of preferred codon usage of the host cell.

“Synthetic nucleic acid fragments” can be assembled from oligonucleotide building blocks that are chemically synthesized using procedures known to those skilled in the art. These building blocks are ligated and annealed to form larger nucleic acid fragments which may then be enzymatically assembled to construct the entire desired nucleic acid fragment. “Chemically synthesized”, as related to nucleic acid fragment, means that the component nucleotides were assembled in vitro. Manual chemical synthesis of nucleic acid fragments may be accomplished using well established procedures, or automated chemical synthesis can be performed using one of a number of commercially available machines. Accordingly, the nucleic acid fragments can be tailored for optimal gene expression based on optimization of nucleotide sequence to reflect the codon bias of the host cell. The skilled artisan appreciates the likelihood of successful gene expression if codon usage is biased towards those codons favored by the host. Determination of preferred codons can be based on a survey of genes derived from the host cell where sequence information is available.

“Gene” refers to a nucleic acid fragment that expresses a specific protein, including regulatory sequences preceding (5′ non-coding sequences) and following (3′ non-coding sequences) the coding sequence. “Native gene” refers to a gene as found in nature with its own regulatory sequences. “Chimeric gene” refers any gene that is not a native gene, comprising regulatory and coding sequences that are not found together in nature. Accordingly, a chimeric gene may comprise regulatory sequences and coding sequences that are derived from different sources, or regulatory sequences and coding sequences derived from the same source, but arranged in a manner different than that found in nature. “Endogenous gene” refers to a native gene in its natural location in the genome of an organism. A “foreign” gene refers to a gene not normally found in the host organism, but that is introduced into the host organism by gene transfer. Foreign genes can comprise native genes inserted into a non-native organism, or chimeric genes. A “transgene” is a gene that has been introduced into the genome by a transformation procedure.

“Coding sequence” refers to a nucleotide sequence that codes for a specific amino acid sequence. “Regulatory sequences” refer to nucleotide sequences located upstream (5′ non-coding sequences), within, or downstream (3′ non-coding sequences) of a coding sequence, and which influence the transcription, RNA processing or stability, or translation of the associated coding sequence. Regulatory sequences may include promoters, translation leader sequences, introns, and polyadenylation recognition sequences.

“Promoter” refers to a nucleotide sequence capable of controlling the expression of a coding sequence or functional RNA. In general, a coding sequence is located 3′ to a promoter sequence. The promoter sequence consists of proximal and more distal upstream elements, the latter elements often referred to as enhancers. Accordingly, an “enhancer” is a nucleotide sequence which can stimulate promoter activity and may be an innate element of the promoter or a heterologous element inserted to enhance the level or tissue-specificity of a promoter. Promoters may be derived in their entirety from a native gene, or be composed of different elements derived from different promoters found in nature, or even comprise synthetic nucleotide segments. It is understood by those skilled in the art that different promoters may direct the expression of a gene in different tissues or cell types, or at different stages of development, or in response to different environmental conditions. Promoters which cause a nucleic acid fragment to be expressed in most cell types at most times are commonly referred to as “constitutive promoters”. New promoters of various types useful in plant cells are constantly being discovered; numerous examples may be found in the compilation by Okamuro and Goldberg (1989) Biochemistry of Plants 15:1-82. It is further recognized that since in most cases the exact boundaries of regulatory sequences have not been completely defined, nucleic acid fragments of different lengths may have identical promoter activity.

The “translation leader sequence” refers to a nucleotide sequence located between the promoter sequence of a gene and the coding sequence. The translation leader sequence is present in the fully processed mRNA upstream of the translation start sequence. The translation leader sequence may affect processing of the primary transcript to mRNA, mRNA stability or translation efficiency. Examples of translation leader sequences have been described (Turner and Foster (1995) Mol. Biotechnol. 3:225-236).

The “3′ non-coding sequences” refer to nucleotide sequences located downstream of a coding sequence and include polyadenylation recognition sequences and other sequences encoding regulatory signals capable of affecting mRNA processing or gene expression. The polyadenylation signal is usually characterized by affecting the addition of polyadenylic acid tracts to the 3′ end of the mRNA precursor. The use of different 3′ non-coding sequences is exemplified by Ingelbrecht et al. (1 989) Plant Cell 1:671-680.

“RNA transcript” refers to the product resulting from RNA polymerase-catalyzed transcription of a DNA sequence. When the RNA transcript is a perfect complementary copy of the DNA sequence, it is referred to as the primary transcript or it may be a RNA sequence derived from posttranscriptional processing of the primary transcript and is referred to as the mature RNA. “Messenger RNA (mRNA)” refers to the RNA that is without introns and that can be translated into polypeptide by the cell. “cDNA” refers to a double-stranded DNA that is complementary to and derived from mRNA. “Sense” RNA refers to an RNA transcript that includes the mRNA and so can be translated into a polypeptide by the cell. “Antisense RNA” refers to an RNA transcript that is complementary to all or part of a target primary transcript or mRNA and that blocks the expression of a target gene (see U.S. Pat. No. 5,107,065, incorporated herein by reference). The complementarity of an antisense RNA may be with any part of the specific nucleotide sequence, i.e., at the 5′ non-coding sequence, 3′ non-coding sequence, introns, or the coding sequence. “Functional RNA” refers to sense RNA, antisense RNA, ribozyme RNA, or other RNA that may not be translated but yet has an effect on cellular processes.

The term “operably linked” refers to the association of two or more nucleic acid fragments on a single nucleic acid fragment so that the function of one is affected by the other. For example, a promoter is operably linked with a coding sequence when it is capable of affecting the expression of that coding sequence (i.e., that the coding sequence is under the transcriptional control of the promoter). Coding sequences can be operably linked to regulatory sequences in sense or antisense orientation.

The term “expression”, as used herein, refers to the transcription and stable accumulation of sense (mRNA) or antisense RNA derived from the nucleic acid fragment of the invention. Expression may also refer to translation of mRNA into a polypeptide. “Antisense inhibition” refers to the production of antisense RNA transcripts capable of suppressing the expression of the target protein. “Overexpression” refers to the production of a gene product in transgenic organisms that exceeds levels of production in normal or non-transformed organisms. “Co-suppression” refers to the production of sense RNA transcripts capable of suppressing the expression of identical or substantially similar foreign or endogenous genes (U.S. Pat. No. 5,231,020, incorporated herein by reference).

“Altered levels” refers to the production of gene product(s) in transgenic organisms in amounts or proportions that differ from that of normal or non-transformed organisms.

“Mature” protein refers to a post-translationally processed polypeptide; i.e., one from which any pre- or propeptides present in the primary translation product have been removed. “Precursor” protein refers to the primary product of translation of mRNA; i.e., with pre- and propeptides still present. Pre- and propeptides may be but are not limited to intracellular localization signals.

A “chloroplast transit peptide” is an amino acid sequence which is translated in conjunction with a protein and directs the protein to the chloroplast or other plastid types present in the cell in which the protein is made. “Chloroplast transit sequence” refers to a nucleotide sequence that encodes a chloroplast transit peptide. A “signal peptide” is an amino acid sequence which is translated in conjunction with a protein and directs the protein to the secretory system (Chrispeels (1991) Ann. Rev. Plant Phys. Plant Mol. Biol. 42:21-53). If the protein is to be directed to a vacuole a vacuolar targeting signal (supra) can further be added, or if to the endoplasmic reticulum, an endoplasmic reticulum retention signal (supra) may be added. If the protein is to be directed to the nucleus, any signal peptide present should be removed and instead a nuclear localization signal included (Raikhel (1992) Plant Phys. 100:1627-1632).

“Transformation” refers to the transfer of a nucleic acid fragment into the genome of a host organism, resulting in genetically stable inheritance. Host organisms containing the transformed nucleic acid fragments are referred to as “transgenic” organisms. Examples of methods of plant transformation include Agrobacterium-mediated transformation (De Blaere et al. (1987) Meth. Enzymol. 143:277) and particle-accelerated or “gene gun” transformation technology (Klein et al. (1987) Nature (London) 327:70-73; U.S. Pat. No. 4,945,050, incorporated herein by reference).

Standard recombinant DNA and molecular cloning techniques used herein are well known in the art and are described more fully in Sambrook et al. Molecular Cloning. A Laboratory Manual; Cold Spring Harbor Laboratory Press: Cold Spring Harbor, 1989 (hereinafter “Maniatis”).

Nucleic acid fragments encoding at least a portion of several polyphenol oxidase enzymes have been isolated and identified by comparison of random plant cDNA sequences to public databases containing nucleotide and protein sequences using the BLAST algorithms well known to those skilled in the art. The nucleic acid fragments of the instant invention may be used to isolate cDNAs and genes encoding homologous proteins from the same or other plant species. Isolation of homologous genes using sequence-dependent protocols is well known in the art. Examples of sequence-dependent protocols include, but are not limited to, methods of nucleic acid hybridization, and methods of DNA and RNA amplification as exemplified by various uses of nucleic acid amplification technologies (e.g., polymerase chain reaction, ligase chain reaction).

For example, genes encoding other polyphenol oxidase either as cDNAs or genomic DNAs, could be isolated directly by using all or a portion of the instant nucleic acid fragments as DNA hybridization probes to screen libraries from any desired plant employing methodology well known to those skilled in the art. Specific oligonucleotide probes based upon the instant nucleic acid sequences can be designed and synthesized by methods known in the art (Maniatis). Moreover, the entire sequences can be used directly to synthesize DNA probes by methods known to the skilled artisan such as random primer DNA labeling, nick translation, or end-labeling techniques, or RNA probes using available in vitro transcription systems. In addition, specific primers can be designed and used to amplify a part or all of the instant sequences. The resulting amplification products can be labeled directly during amplification reactions or labeled after amplification reactions, and used as probes to isolate full length cDNA or genomic fragments under conditions of appropriate stringency.

In addition, two short segments of the instant nucleic acid fragments may be used in polymerase chain reaction protocols to amplify longer nucleic acid fragments encoding homologous genes from DNA or RNA. The polymerase chain reaction may also be performed on a library of cloned nucleic acid fragments wherein the sequence of one primer is derived from the instant nucleic acid fragments, and the sequence of the other primer takes advantage of the presence of the polyadenylic acid tracts to the 3′ end of the mRNA precursor encoding plant genes. Alternatively, the second primer sequence may be based upon sequences derived from the cloning vector. For example, the skilled artisan can follow the RACE protocol (Frohman et al. (1988) Proc. Natl. Acad. Sci. USA 85:8998-9002) to generate cDNAs by using PCR to amplify copies of the region between a single point in the transcript and the 3′ or 5′ end. Primers oriented in the 3′ and 5′ directions can be designed from the instant sequences. Using commercially available 3′ RACE or 5′ RACE systems (BRL), specific 3′ or 5′ cDNA fragments can be isolated (Ohara et al. (1989) Proc. Natl. Acad. Sci. USA 86:5673-5677; Loh et al. (1989) Science 243:217-220). Products generated by the 3′ and 5′ RACE procedures can be combined to generate full-length cDNAs (Frohman and Martin (1989) Techniques 1:165). Consequently, a polynucleotide comprising a nucleotide sequence of at least one of 60 (preferably one of at least 40, most preferably one of at least 30) contiguous nucleotides derived from a nucleotide sequence selected from the group consisting of SEQ ID NOs:1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 15, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45 and the complement of such nucleotide sequences may be used in such methods to obtain a nucleic acid fragment encoding a substantial portion of an amino acid sequence of a polypeptide. The present invention relates to a method of obtaining a nucleic acid fragment encoding a substantial portion of a polypeptide of a gene (such as polyphenol oxidse) preferably a substantial portion of a plant polypeptide of a gene, comprising the steps of: synthesizing an oligonucleotide primer comprising a nucleotide sequence of at least one of 60 (preferably at least one of 40, most preferably at least one of 30) contiguous nucleotides derived from a nucleotide sequence selected from the group consisting of SEQ ID NOs:1, 3, 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, 33, 35, 37, 39, 41, 43, 45 and the complement of such nucleotide sequences; and amplifying a nucleic acid fragment (preferably a cDNA inserted in a cloning vector) using the oligonucleotide primer. The amplified nucleic acid fragment preferably will encode a portion of a polypeptide (polyphenol oxidase).

Availability of the instant nucleotide and deduced amino acid sequences facilitates immunological screening of cDNA expression libraries. Synthetic peptides representing portions of the instant amino acid sequences may be synthesized. These peptides can be used to immunize animals to produce polyclonal or monoclonal antibodies with specificity for peptides or proteins comprising the amino acid sequences. These antibodies can be then be used to screen cDNA expression libraries to isolate full-length cDNA clones of interest (Lerner (1984) Adv. Immunol. 36:1-34; Maniatis).

The nucleic acid fragments of the instant invention may be used to create transgenic plants in which the disclosed polypeptides are present at higher or lower levels than normal or in cell types or developmental stages in which they are not normally found. This would have the effect of altering the level of polyphenol oxidase activity in those cells.

Overexpression of the proteins of the instant invention may be accomplished by first constructing a chimeric gene in which the coding region is operably linked to a promoter capable of directing expression of a gene in the desired tissues at the desired stage of development. The chimeric gene may comprise promoter sequences and translation leader sequences derived from the same genes. 3′ Non-coding sequences encoding transcription termination signals may also be provided. The instant chimeric gene may also comprise one or more introns in order to facilitate gene expression.

Plasmid vectors comprising the isolated polynucleotide (or chimeric gene) may be constructed. The choice of plasmid vector is dependent upon the method that will be used to transform host plants. The skilled artisan is well aware of the genetic elements that must be present on the plasmid vector in order to successfully transform, select and propagate host cells containing the chimeric gene. The skilled artisan will also recognize that different independent transformation events will result in different levels and patterns of expression (Jones et al. (1985) EMBO J. 4:2411-2418; De Almeida et al. (1989) Mol. Gen. Genetics 218:78-86), and thus that multiple events must be screened in order to obtain lines displaying the desired expression level and pattern. Such screening may be accomplished by Southern analysis of DNA, Northern analysis of mRNA expression. Western analysis of protein expression, or phenotypic analysis.

For some applications it may be useful to direct the instant polypeptides to different cellular compartments, or to facilitate its secretion from the cell. It is thus envisioned that the chimeric gene described above may be further supplemented by directing the coding sequence to encode the instant polypeptides with appropriate intracellular targeting sequences such as transit sequences (Keegstra (1989) Cell 56:247-253), signal sequences or sequences encoding endoplasmic reticulum localization (Chrispeels (1991) Ann. Rev. Plant Phys. Plant Mol. Biol. 42:21-53), or nuclear localization signals (Raikhel (1992) Plant Phys. 100:1627-1632) with or without removing targeting sequences that are already present. While the references cited give examples of each of these, the list is not exhaustive and more targeting signals of use may be discovered in the future.

It may also be desirable to reduce or eliminate expression of genes encoding the instant polypeptides in plants for some applications. In order to accomplish this, a chimeric gene designed for co-suppression of the instant polypeptide can be constructed by linking a gene or gene fragment encoding that polypeptide to plant promoter sequences. Alternatively, a chimeric gene designed to express antisense RNA for all or part of the instant nucleic acid fragment can be constructed by linking the gene or gene fragment in reverse orientation to plant promoter sequences. Either the co-suppression or antisense chimeric genes could be introduced into plants via transformation wherein expression of the corresponding endogenous genes are reduced or eliminated.

Molecular genetic solutions to the generation of plants with altered gene expression have a decided advantage over more traditional plant breeding approaches. Changes in plant phenotypes can be produced by specifically inhibiting expression of one or more genes by antisense inhibition or cosuppression (U.S. Pat. Nos. 5,190,931, 5,107.065 and 5,283,323). An antisense or cosuppression construct would act as a dominant negative regulator of gene activity. While conventional mutations can yield negative regulation of gene activity these effects are most likely recessive. The dominant negative regulation available with a transgenic approach may be advantageous from a breeding perspective. In addition, the ability to restrict the expression of specific phenotype to the reproductive tissues of the plant by the use of tissue specific promoters may confer agronomic advantages relative to conventional mutations which may have an effect in all tissues in which a mutant gene is ordinarily expressed.

The person skilled in the art will know that special considerations are associated with the use of antisense or cosuppression technologies in order to reduce expression of particular genes. For example, the proper level of expression of sense or antisense genes may require the use of different chimeric genes utilizing different regulatory elements known to the skilled artisan. Once transgenic plants are obtained by one of the methods described above, it will be necessary to screen individual transgenics for those that most effectively display the desired phenotype. Accordingly, the skilled artisan will develop methods for screening large numbers of transformants. The nature of these screens will generally be chosen on practical grounds. For example, one can screen by looking for changes in gene expression by using antibodies specific for the protein encoded by the gene being suppressed, or one could establish assays that specifically measure enzyme activity. A preferred method will be one which allows large numbers of samples to be processed rapidly, since it will be expected that a large number of transformants will be negative for the desired phenotype.

The instant polypeptides (or portions thereof) may be produced in heterologous host cells, particularly in the cells of microbial hosts, and can be used to prepare antibodies to the these proteins by methods well known to those skilled in the art. The antibodies are useful for detecting the polypeptides of the instant invention in situ in cells or in vitro in cell extracts. Preferred heterologous host cells for production of the instant polypeptides are microbial hosts. Microbial expression systems and expression vectors containing regulatory sequences that direct high level expression of foreign proteins are well known to those skilled in the art. Any of these could be used to construct a chimeric gene for production of the instant polypeptides. This chimeric gene could then be introduced into appropriate microorganisms via transformation to provide high level expression of the encoded polyphenol oxidase enzyme. An example of a vector for high level expression of the instant polypeptides in a bacterial host is provided (Example 6).

All or a substantial portion of the nucleic acid fragments of the instant invention may also be used as probes for genetically and physically mapping the genes that they are a part of, and as markers for traits linked to those genes. Such information may be useful in plant breeding in order to develop lines with desired phenotypes. For example, the instant nucleic acid fragments may be used as restriction fragment length polymorphism (RFLP) markers. Southern blots (Maniatis) of restriction-digested plant genomic DNA may be probed with the nucleic acid fragments of the instant invention. The resulting banding patterns may then be subjected to genetic analyses using computer programs such as MapMaker (Lander et al. (1987) Genomics 1:174-181) in order to construct a genetic map. In addition, the nucleic acid fragments of the instant invention may be used to probe Southern blots containing restriction endonuclease-treated genomic DNAs of a set of individuals representing parent and progeny of a defined genetic cross. Segregation of the DNA polymorphisms is noted and used to calculate the position of the instant nucleic acid sequence in the genetic map previously obtained using this population (Botstein et al. (1980) Am. J. Hum. Genet. 32:314-331).

The production and use of plant gene-derived probes for use in genetic mapping is described in Bernatzky and Tanksley (1986) Plant Mol. Biol. Reporter 4:37-41. Numerous publications describe genetic mapping of specific cDNA clones using the methodology outlined above or variations thereof. For example, F2 intercross populations, backcross populations, randomly mated populations, near isogenic lines, and other sets of individuals may be used for mapping. Such methodologies are well known to those skilled in the art.

Nucleic acid probes derived from the instant nucleic acid sequences may also be used for physical mapping (i.e., placement of sequences on physical maps; see Hoheisel et al. In: Nonmammalian Genomic Analysis. A Practical Guide, Academic press 1996, pp. 319-346, and references cited therein).

In another embodiment, nucleic acid probes derived from the instant nucleic acid sequences may be used in direct fluorescence in situ hybridization (FISH) mapping (Trask (1991) Trends Genet. 7:149-154). Although current methods of FISH mapping favor use of large clones (several to several hundred KB; see Laan et al. (1995) Genome Res. 5:13-20), improvements in sensitivity may allow performance of FISH mapping using shorter probes.

A variety of nucleic acid amplification-based methods of genetic and physical mapping may be carried out using the instant nucleic acid sequences. Examples include allele-specific amplification (Kazazian (1989) J. Lab. Clin. Med. 11:95-96), polymorphism of PCR-amplified fragments (CAPS; Sheffield et al. (1993) Genomics 16:325-332), allele-specific ligation (Landegren et al. (1988) Science 241:1077-1080), nucleotide extension reactions (Sokolov (1990) Nucleic Acid Res. 18:3671), Radiation Hybrid Mapping (Walter et al. (1997) Nat. Genet. 7:22-28) and Happy Mapping (Dear and Cook (1989) Nucleic Acid Res. 17:6795-6807). For these methods, the sequence of a nucleic acid fragment is used to design and produce primer pairs for use in the amplification reaction or in primer extension reactions. The design of such primers is well known to those skilled in the art. In methods employing PCR-based genetic mapping, it may be necessary to identify DNA sequence differences between the parents of the mapping cross in the region corresponding to the instant nucleic acid sequence. This, however, is generally not necessary for mapping methods.

Loss of function mutant phenotypes may be identified for the instant cDNA clones either by targeted gene disruption protocols or by identifying specific mutants for these genes contained in a maize population carrying mutations in all possible genes (Ballinger and Benzer (1989) Proc. Natl. Acad. Sci USA 86:9402-9406; Koes et al. (1995) Proc. Natl. Acad Sci USA 92:8149-8153; Bensen et al. (1995) Plant Cell 7:75-84). The latter approach may be accomplished in two ways. First, short segments of the instant nucleic acid fragments may be used in polymerase chain reaction protocols in conjunction with a mutation tag sequence primer on DNAs prepared from a population of plants in which Mutator transposons or some other mutation-causing DNA element has been introduced (see Bensen, supra). The amplification of a specific DNA fragment with these primers indicates the insertion of the mutation tag element in or near the plant gene encoding the instant polypeptides. Alternatively, the instant nucleic acid fragment may be used as a hybridization probe against PCR amplification products generated from the mutation population using the mutation tag sequence primer in conjunction with an arbitrary genomic site primer, such as that for a restriction enzyme site-anchored synthetic adaptor. With either method, a plant containing a mutation in the endogenous gene encoding the instant polypeptides can be identified and obtained. This mutant plant can then be used to determine or confirm the natural function of the instant polypeptides disclosed herein.

EXAMPLES

The present invention is further defined in the following Examples, in which all parts and percentages are by weight and degrees are Celsius, unless otherwise stated. It should be understood that these Examples, while indicating preferred embodiments of the invention, are given by way of illustration only. From the above discussion and these Examples, one skilled in the art can ascertain the essential characteristics of this invention, and without departing from the spirit and scope thereof, can make various changes and modifications of the invention to adapt it to various usages and conditions.

Example 1 Composition of cDNA Libraries: Isolation and Sequencing of cDNA Clones

cDNA libraries representing mRNAs from various corn, rice, soybean and wheat tissues were prepared. The characteristics of the libraries are described below.

TABLE 2 cDNA Libraries from Corn, Rice, Soybean and Wheat Library Tissue Clone ccs1c Corn Callus ccs1c.pk002.k13 cpi1c Corn pooled BMS treated with chemicals cpi1c.pk001.o22 related to biochemical compound synthesis** csc1c Corn 20-Day Seedling; Germination csc1c.pk004.a22 Under Cold Stress csi1n Corn Silk* csi1n.pk0036.d5 dms2c African daisy developing seeds dms2c.pk001.k8 p0013 p0013.csdlu31rb p0013.csdlu31rd p0016 Corn Tassel Shoots, Pooled, 0.1-1.4 cm p0016.ctsbd45rc p0016.ctsbd45rf p0016.ctsbw54rb p0018 Corn Seedling After 10 Day Drought, p0018.chssz59rb Heat Shocked for 24 Hours, Harvested After Recovery at Normal Growth Conditions for 8 Hours p0083 Corn Whole Kernels 7 Days p0083.cldcl92r After Pollination p0097 Corn V9*** Whorl Section (7 cm) From p0097.cqraa41r Plant Infected Four Times With European Corn Borer p0107 Corn Whole Kernels 7 Days p0107.cbcau93r After Pollination* p0117 Expanding internode: plants sampled @ p0117.chclp75r the V10*** stage. Internodes 5-9 (the upper 4-5 expanding internodes) p0119 Corn Stage V12*** Ear Shoot With Husk, p0119.cmtnp57r Night Harvested* sfl1 Soybean Immature Flower sfl1.pk0007.c3 sfl1.pk0025.b4 sfl1.pk0041.a9 sfl1.pk0057.e9 sfl1.pk0074.f6 sfl1.pk0095.h1 sfl1.pk0099.a3 sfl1.pk0111.b7 sfl1.pk0122.h9 sfl1.pk126.m8 sfl1.pk132.d21 sfl1.pk133.k3 sgc4c Soybean Cotyledon 14-21 Days After sgs4c.pk002.n13 Germination (¼ yellow) sgc6c Soybean Cotyledon 16-26 Days After sgc6c.pk001.h11 Germination (all yellow) sgc6c.pk001.h13 sgc7c Soybean Cotyledon 18-30 Days After sgc7c.pk001.i6 Germination (yellow and wilting) sgc7c.pk001.o2 sls1c Soybean Infected With Sclerotinia sls1c.pk001.i11 sclerotiorum Mycelium sls1c.pk003.112 sls2c Soybean Infected With Sclerotinia sls2c.pk001.e2 sclerotiorum Mycelium sr1 Soybean Root sr1.pk0024.h11 src3c Soybean 8 Day Old Root Infected With src3c.pk005.d9 Cyst Nematode Heterdera glycenis srr1c Soybean 8-Day-Old Root srr1c.pk002.j24 srr3c Soybean 8-Day-Old Root srr3c.pk003.d19 vs1n Vernonia Seed* vs1n.pk0010.d5 wlm96 Wheat Seedlings 96 Hours After wlm96.pk0023.- Inoculation With Erysiphe graminis f. a11 sp tritici *These libraries were normalized essentially as described in U.S. Pat. No. 5,482,845, incorporated herein by reference. **Chemicals used included sorbitol, egosterol, taxifolin, methotrexate, D-mannose, D-glactose, alpha-amino adipic acid, ancymidol ***Corn developmental stages are explained in the publication “How a corn plant develops” from the Iowa State University Coop. Ext. Service Special Report No. 48 reprinted June 1993.

cDNA libraries may be prepared by any one of many methods available. For example, the cDNAs may be introduced into plasmid vectors by first preparing the cDNA libraries in Uni-ZAP™ XR vectors according to the manufacturer's protocol (Stratagene Cloning Systems, La Jolla, Calif.). The Uni-ZAPT™ XR libraries are converted into plasmid libraries according to the protocol provided by Stratagene. Upon conversion, cDNA inserts will be contained in the plasmid vector pBluescript. In addition, the cDNAs may be introduced directly into precut Bluescript II SK(+) vectors (Stratagene) using T4 DNA ligase (New England Biolabs), followed by transfection into DH10B cells according to the manufacturer's protocol (GIBCO BRL Products). Once the cDNA inserts are in plasmid vectors, plasmid DNAs are prepared from randomly picked bacterial colonies containing recombinant pBluescript plasmids, or the insert cDNA sequences are amplified via polymerase chain reaction using primers specific for vector sequences flanking the inserted cDNA sequences. Amplified insert DNAs or plasmid DNAs are sequenced in dye-primer sequencing reactions to generate partial cDNA sequences (expressed sequence tags or “ESTs”; see Adams et al., (1991) Science 252:1651-1656). The resulting ESTs are analyzed using a Perkin Elmer Model 377 fluorescent sequencer.

Example 2 Identification of cDNA Clones

cDNA clones encoding polyphenol oxidase enzymes were identified by conducting BLAST (Basic Local Alignment Search Tool; Altschul et al. (1993) J. Mol. Biol. 215:403-410) searches for similarity to sequences contained in the BLAST “nr” database (comprising all non-redundant GenBank CDS translations, sequences derived from the 3-dimensional structure Brookhaven Protein Data Bank, the last major release of the SWISS-PROT protein sequence database, EMBL, and DDBJ databases). The cDNA sequences obtained in Example 1 were analyzed for similarity to all publicly available DNA sequences contained in the “nr” database using the BLASTN algorithm provided by the National Center for Biotechnology Information (NCBI). The DNA sequences were translated in all reading frames and compared for similarity to all publicly available protein sequences contained in the “nr” database using the BLASTX algorithm (Gish and States (1993) Nat. Genet. 3:266-272) provided by the NCBI. For convenience, the P-value (probability) of observing a match of a cDNA sequence to a sequence contained in the searched databases merely by chance as calculated by BLAST are reported herein as “pLog” values, which represent the negative of the logarithm of the reported P-value. Accordingly, the greater the pLog value, the greater the likelihood that the cDNA sequence and the BLAST “hit” represent homologous proteins.

Example 3 Characterization of cDNA Clones Encoding Polyphenol Oxidase

The BLASTX search using the EST sequences from clones listed in Table 3 revealed similarity of the polypeptides encoded by the cDNAs to polyphenol oxidase from Malus domestica (NCBI Identifier No. gi 1172584), Vitis vinifera (NCBI Identifier No. gi 1785613), Vica faba (NCBI Identifier No. gi 418754), Vica faba (NCBI Identifier No. gi 1172586), Saccharum sp. (NCBI Identifier No. gi 2737882) and Prunus persica (NCBI Identifier No. gi 4519437). Shown in Table 3 are the BLAST results for individual ESTs (“EST”), the sequences of the entire cDNA inserts comprising the indicated cDNA clones (“FIS”), contigs assembled from two or more ESTs (“Contig”), contigs assembled from an FIS and one or more ESTs (“Contig*”), or sequences encoding the entire protein derived from an FIS, a contig, or an FIS and PCR (“CGS”):

TABLE 3 BLAST Results for Sequences Encoding Polypeptides Homologous to Malus domestica, Vitis vinifera, Vica faba, Saccharum sp. and Prunus persica Polyphenol Oxidase Clone Status BLAST pLog Score cpi1c.pk001.o22 FIS  70.70 (gi 1172584) Contig Composed of: Contig  27.22 (gi 1785613) p0083.cldc192r p0107.cbcau93r sfl1.pk0111.b7 CGS >254.00 (gi 1172584) wlm96.pk0023.a11 CGS  160.00 (gi 1172584) sfl1.pk133.k3 CGS >254.00 (gi 418754) Contig composed of: Contig  13.40 (gi 1172584) sgc6c.pk001.h11 sgc6c.pk001.h13 sls1c.pk001.i11 CGS >254.00 (gi 418754) src3c.pk005.d9 CGS  173.00 (gi 1172586) sfl1.pk126.m8 CGS  127.00 (gi 418754) sfl1.pk0007.c3 CGS  150.00 (gi 1172584) Contig composed of: Contig  100.00 (gi 2737882) ccs1c.pk002.k13 p0013.csdlu31rb p0013.csdlu31rd p0117.chclp75r Contig composed of: Contig >254.00 (gi 2737882) csc1c.pk004.a22 csi1n.pk0036.d5 p0016.ctsbd45rc p0016.ctsbd45rf p0016.ctsbw54rb p0018.chssz59rb p0119.cmtnp57r p0097.cqraa41r EST   9.04 (gi 2737882) sr1.pk0024.h11 EST  56.40 (gi 4519437)

The data in Table 4 represents a calculation of the percent identity of the amino acid sequences set forth in SEQ ID NOs:4, 6, 10, 14, 20, 24, 28, 32, 34, 36, 38, 40, 42, 44, 46 and 48 and the Malus domeslica, Vitis vinifera, Vica faba, Saccharum sp. and Prunus persica sequences.

TABLE 4 Percent Identity of Amino Acid Sequences Deduced From the Nucleotide Sequences of cDNA Clones Encoding Polypeptides Homologous to Malus domestica, Vitis vinifera, Vica faba, Saccharum sp. and Prunus persica Polyphenol Oxidase SEQ ID NO. Percent Identity to  4 44% (gi 1172584)  6 42% (gi 11785613) 10 60% (gi 1172584) 14 47% (gi 1172584) 20 62% (gi 418754) 24 28% (gi 1172584) 28 56% (gi 418754) 32 46% (gi 1172586) 34 37% (gi 418754) 36 40% (gi 1172584) 38 46% (gi 2737882) 40 74% (gi 2737882) 42 35% (gi 2737882) 44 71% (gi 4519437)

Sequence alignments and percent identity calculations were performed using the Megalign program of the LASERGENE bioinformatics computing suite (DNASTAR Inc., Madison, Wis.). Multiple alignment of the sequences was performed using the Clustal method of alignment (Higgins and Sharp (1989) CABIOS. 5:151-153) with the default parameters (GAP PENALTY=10, GAP LENGTH PENALTY=10). Default parameters for pairwise alignments using the Clustal method were KTUPLE 1, GAP PENALTY=3, WINDOW=5 and DIAGONALS SAVED=5. Sequence alignments and BLAST scores and probabilities indicate that the nucleic acid fragments comprising the instant cDNA clones encode a substantial portion of a polyphenol oxidase. These sequences represent the first african daisy, corn, soybean, vernonia and wheat sequences encoding polyphenol oxidase.

Example 4 Expression of Chimeric Genes in Monocot Cells

A chimeric gene comprising a cDNA encoding the instant polypeptides in sense orientation with respect to the maize 27 kD zein promoter that is located 5′ to the cDNA fragment, and the 10 kD zein 3′ end that is located 3′ to the cDNA fragment, can be constructed. The cDNA fragment of this gene may be generated by polymerase chain reaction (PCR) of the cDNA clone using appropriate oligonucleotide primers. Cloning sites (NcoI or SmaI) can be incorporated into the oligonucleotides to provide proper orientation of the DNA fragment when inserted into the digested vector pML103 as described below. Amplification is then performed in a standard PCR. The amplified DNA is then digested with restriction enzymes NcoI and SmaI and fractionated on an agarose gel. The appropriate band can be isolated from the gel and combined with a 4.9 kb NcoI-SmaI fragment of the plasmid pML103. Plasmid pML103 has been deposited under the terms of the Budapest Treaty at ATCC (American Type Culture Collection, 10801 University Blvd., Manassas, Va. 20110-2209), and bears accession number ATCC 97366. The DNA segment from pML103 contains a 1.05 kb SalI-NcoI promoter fragment of the maize 27 kD zein gene and a 0.96 kb SmaI-SalI fragment from the 3′ end of the maize 10 kD zein gene in the vector pGem9Zf(+) (Promega). Vector and insert DNA can be ligated at 15° C. overnight, essentially as described (Maniatis). The ligated DNA may then be used to transform E. coli XL1-Blue (Epicurian Coli XL-1 Blue™; Stratagene). Bacterial transformants can be screened by restriction enzyme digestion of plasmid DNA and limited nucleotide sequence analysis using the dideoxy chain termination method (Sequenase™ DNA Sequencing Kit; U.S. Biochemical). The resulting plasmid construct would comprise a chimeric gene encoding, in the 5′ to 3′ direction, the maize 27 kD zein promoter, a cDNA fragment encoding the instant polypeptides, and the 10 kD zein 3′ region.

The chimeric gene described above can then be introduced into corn cells by the following procedure. Immature corn embryos can be dissected from developing caryopses derived from crosses of the inbred corn lines H99 and LH132. The embryos are isolated 10 to 11 days after pollination when they are 1.0 to 1.5 mm long. The embryos are then placed with the axis-side facing down and in contact with agarose-solidified N6 medium (Chu et al. (1975) Sci. Sin. Peking 18:659-668). The embryos are kept in the dark at 27° C. Friable embryogenic callus consisting of undifferentiated masses of cells with somatic proembryoids and embryoids borne on suspensor structures proliferates from the scutellum of these immature embryos. The embryogenic callus isolated from the primary explant can be cultured on N6 medium and sub-cultured on this medium every 2 to 3 weeks.

The plasmid, p35S/Ac (obtained from Dr. Peter Eckes, Hoechst Ag, Frankfurt. Germany) may be used in transformation experiments in order to provide for a selectable marker. This plasmid contains the Pat gene (see European Patent Publication 0 242 236) which encodes phosphinothricin acetyl transferase (PAT). The enzyme PAT confers resistance to herbicidal glutamine synthetase inhibitors such as phosphinothricin. The pat gene in p35S/Ac is under the control of the 35S promoter from Cauliflower Mosaic Virus (Odell et al. (1985) Nature 313:810-812) and the 3′ region of the nopaline synthase gene from the T-DNA of the Ti plasmid of Agrobacterium tumefaciens.

The particle bombardment method (Klein et al. (1987) Nature 327:70-73) may be used to transfer genes to the callus culture cells. According to this method, gold particles (1 μm in diameter) are coated with DNA using the following technique. Ten μg of plasmid DNAs are added to 50 μL of a suspension of gold particles (60 mg per mL). Calcium chloride (50 μL of a 2.5 M solution) and spermidine free base (20 μL of a 1.0 M solution) are added to the particles. The suspension is vortexed during the addition of these solutions. After 10 minutes, the tubes are briefly centrifuged (5 sec at 15,000 rpm) and the supernatant removed. The particles are resuspended in 200 μL of absolute ethanol, centrifuged again and the supernatant removed. The ethanol rinse is performed again and the particles resuspended in a final volume of 30 μL of ethanol. An aliquot (5 μL) of the DNA-coated gold particles can be placed in the center of a Kapton™ flying disc (Bio-Rad Labs). The particles are then accelerated into the corn tissue with a Biolistic™ PDS-1000/He (Bio-Rad Instruments, Hercules Calif.), using a helium pressure of 1000 psi, a gap distance of 0.5 cm and a flying distance of 1.0 cm.

For bombardment, the embryogenic tissue is placed on filter paper over agarose-solidified N6 medium. The tissue is arranged as a thin lawn and covered a circular area of about 5 cm in diameter. The petri dish containing the tissue can be placed in the chamber of the PDS-1000/He approximately 8 cm from the stopping screen. The air in the chamber is then evacuated to a vacuum of 28 inches of Hg. The macrocarrier is accelerated with a helium shock wave using a rupture membrane that bursts when the He pressure in the shock tube reaches 1000 psi.

Seven days after bombardment the tissue can be transferred to N6 medium that contains gluphosinate (2 mg per liter) and lacks casein or proline. The tissue continues to grow slowly on this medium. After an additional 2 weeks the tissue can be transferred to fresh N6 medium containing gluphosinate. After 6 weeks, areas of about 1 cm in diameter of actively growing callus can be identified on some of the plates containing the glufosinate-supplemented medium. These calli may continue to grow when sub-cultured on the selective medium.

Plants can be regenerated from the transgenic callus by first transferring clusters of tissue to N6 medium supplemented with 0.2 mg per liter of 2,4-D. After two weeks the tissue can be transferred to regeneration medium (Fromm et al. (1990) Bio/Technology 8:833-839).

Example 5 Expression of Chimeric Genes in Dicot Cells

A seed-specific expression cassette composed of the promoter and transcription terminator from the gene encoding the β subunit of the seed storage protein phaseolin from the bean Phaseolus vulgaris (Doyle et al. (1986) J. Biol. Chem. 261:9228-9238) can be used for expression of the instant polypeptides in transformed soybean. The phaseolin cassette includes about 500 nucleotides upstream (5′) from the translation initiation codon and about 1650 nucleotides downstream (3′) from the translation stop codon of phaseolin. Between the 5′ and 3′ regions are the unique restriction endonuclease sites Nco I (which includes the ATG translation initiation codon), Sma I, Kpn I and Xba I. The entire cassette is flanked by Hind III sites.

The cDNA fragment of this gene may be generated by polymerase chain reaction (PCR) of the cDNA clone using appropriate oligonucleotide primers. Cloning sites can be incorporated into the oligonucleotides to provide proper orientation of the DNA fragment when inserted into the expression vector. Amplification is then performed as described above, and the isolated fragment is inserted into a pUC18 vector carrying the seed expression cassette.

Soybean embryos may then be transformed with the expression vector comprising sequences encoding the instant polypeptides. To induce somatic embryos, cotyledons, 3-5 mm in length dissected from surface sterilized, immature seeds of the soybean cultivar A2872, can be cultured in the light or dark at 26° C. on an appropriate agar medium for 6-10 weeks. Somatic embryos which produce secondary embryos are then excised and placed into a suitable liquid medium. After repeated selection for clusters of somatic embryos which multiplied as early, globular staged embryos, the suspensions are maintained as described below.

Soybean embryogenic suspension cultures can maintained in 35 mL liquid media on a rotary shaker, 150 rpm, at 26° C. with florescent lights on a 16:8 hour day/night schedule. Cultures are subcultured every two weeks by inoculating approximately 35 mg of tissue into 35 mL of liquid medium.

Soybean embryogenic suspension cultures may then be transformed by the method of particle gun bombardment (Klein et al. (1987) Nature (London) 327:70-73, U.S. Pat. No. 4,945,050). A DuPont Biolistic™ PDS1000/HE instrument (helium retrofit) can be used for these transformations.

A selectable marker gene which can be used to facilitate soybean transformation is a chimeric gene composed of the 35S promoter from Cauliflower Mosaic Virus (Odell et al. (1985) Nature 313:810-812), the hygromycin phosphotransferase gene from plasmid pJR225 (from E. coli; Gritz et al.(l983) Gene 25:179-188) and the 3′ region of the nopaline synthase gene from the T-DNA of the Ti plasmid of Agrobacterium tumefaciens. The seed expression cassette comprising the phaseolin 5′ region, the fragment encoding the instant polypeptides and the phaseolin 3′ region can be isolated as a restriction fragment. This fragment can then be inserted into a unique restriction site of the vector carrying the marker gene.

To 50 μL of a 60 mg/mL 1 μm gold particle suspension is added (in order): 5 μL DNA (1 μg/μL), 20 μl spermidine (0.1 M), and 50 μL CaCl₂ (2.5 M). The particle preparation is then agitated for three minutes, spun in a microfuge for 10 seconds and the supernatant removed. The DNA-coated particles are then washed once in 400 μL 70% ethanol and resuspended in 40 μL of anhydrous ethanol. The DNA/particle suspension can be sonicated three times for one second each. Five μL of the DNA-coated gold particles are then loaded on each macro carrier disk.

Approximately 300-400 mg of a two-week-old suspension culture is placed in an empty 60×15 mm petri dish and the residual liquid removed from the tissue with a pipette. For each transformation experiment, approximately 5-10 plates of tissue are normally bombarded. Membrane rupture pressure is set at 1100 psi and the chamber is evacuated to a vacuum of 28 inches mercury. The tissue is placed approximately 3.5 inches away from the retaining screen and bombarded three times. Following bombardment, the tissue can be divided in half and placed back into liquid and cultured as described above.

Five to seven days post bombardment, the liquid media may be exchanged with fresh media, and eleven to twelve days post bombardment with fresh media containing 50 mg/mL hygromycin. This selective media can be refreshed weekly. Seven to eight weeks post bombardment, green, transformed tissue may be observed growing from untransformed, necrotic embryogenic clusters. Isolated green tissue is removed and inoculated into individual flasks to generate new, clonally propagated, transformed embryogenic suspension cultures. Each new line may be treated as an independent transformation event. These suspensions can then be subcultured and maintained as clusters of immature embryos or regenerated into whole plants by maturation and germination of individual somatic embryos.

Example 6 Expression of Chimeric Genes in Microbial Cells

The cDNAs encoding the instant polypeptides can be inserted into the T7 E. coli expression vector pBT430. This vector is a derivative of pET-3a (Rosenberg et al. (1987) Gene 56:125-135) which employs the bacteriophage T7 RNA polymerase/T7 promoter system. Plasmid pBT430 was constructed by first destroying the EcoR I and Hind III sites in pET-3a at their original positions. An oligonucleotide adaptor containing EcoR I and Hind III sites was inserted at the BamH I site of pET-3a. This created pET-3aM with additional unique cloning sites for insertion of genes into the expression vector. Then, the Nde I site at the position of translation initiation was converted to an Nco I site using oligonucleotide-directed mutagenesis. The DNA sequence of pET-3aM in this region, 5′-CATATGG, was converted to 5′-CCCATGG in pBT430.

Plasmid DNA containing a cDNA may be appropriately digested to release a nucleic acid fragment encoding the protein. This fragment may then be purified on a 1% NuSieve GTG™ low melting agarose gel (FMC). Buffer and agarose contain 10 μg/ml ethidium bromide for visualization of the DNA fragment. The fragment can then be purified from the agarose gel by digestion with GELase™ (Epicentre Technologies) according to the manufacturer's instructions, ethanol precipitated, dried and resuspended in 20 μL of water. Appropriate oligonucleotide adapters may be ligated to the fragment using T4 DNA ligase (New England Biolabs, Beverly, Mass.). The fragment containing the ligated adapters can be purified from the excess adapters using low melting agarose as described above. The vector pBT430 is digested, dephosphorylated with alkaline phosphatase (NEB) and deproteinized with phenol/chloroform as described above. The prepared vector pBT430 and fragment can then be ligated at 16° C. for 15 hours followed by transformation into DH5 electrocompetent cells (GIBCO BRL). Transformants can be selected on agar plates containing LB media and 100 μg/mL ampicillin. Transformants containing the gene encoding the instant polypeptides are then screened for the correct orientation with respect to the T7 promoter by restriction enzyme analysis.

For high level expression, a plasmid clone with the cDNA insert in the correct orientation relative to the T7 promoter can be transformed into E. coli strain BL21 (DE3) (Studier et al. (1986) J. Mol. Biol. 189:113-130). Cultures are grown in LB medium containing ampicillin (100 mg/L) at 25° C. At an optical density at 600 nm of approximately 1, IPTG (isopropylthio-β-galactoside, the inducer) can be added to a final concentration of 0.4 mM and incubation can be continued for 3 h at 25°. Cells are then harvested by centrifugation and re-suspended in 50 μL of 50 mM Tris-HCl at pH 8.0 containing 0.1 mM DTT and 0.2 mM phenyl methylsulfonyl fluoride. A small amount of 1 mm glass beads can be added and the mixture sonicated 3 times for about 5 seconds each time with a microprobe sonicator. The mixture is centrifuged and the protein concentration of the supernatant determined. One μg of protein from the soluble fraction of the culture can be separated by SDS-polyacrylamide gel electrophoresis. Gels can be observed for protein bands migrating at the expected molecular weight.

Various modifications of the invention in addition to those shown and described herein will be apparent to those skilled in the art from the foregoing description. Such modifications are also intended to fall within the scope of the appended claims.

The disclosure of each reference set forth above is incorporated herein by reference in its entirety.

46 1 512 DNA Zea mays unsure (489) n = a, c, g or t 1 ggacatggcc tccatttcgc atttaattgc taagccagct ccagctgcca cctttcctct 60 atcccttccg agaacgagct ccggcttcag gcctcgccgc gttaccgtcc agcgcgtctc 120 gtgcgcatct cccagaggcg aacgctccga gccagacgcc caaaagcacg accgccgcga 180 cgtcctcctc ggcctcggag cgctcggtgc cagtgccacc gctaccctgg cgtccgcgcg 240 ccgcgccggc gccgaccccg tcgccacgcc cgacatctct tcctgcggcc aagcgaacct 300 tccggtgagc gccaacgtgc tgacgtgctg cccgccgccc tcgagcgcgc tgcccgtgga 360 cttcatcctc cccgacgcca cgtccttgcc gctccggacg cgccccgccg cgcactcggt 420 caccacggac tacgtcgcca aagttcaacg ccgggatcgc tgcgatgaag gggctcccgg 480 cgggacganc cgcgtagctt cgcggcgcan gg 512 2 150 PRT Zea mays 2 Met Ala Ser Ile Ser His Leu Ile Ala Lys Pro Ala Pro Ala Ala Thr 1 5 10 15 Phe Pro Leu Ser Leu Pro Arg Thr Ser Ser Gly Phe Arg Pro Arg Arg 20 25 30 Val Thr Val Gln Arg Val Ser Cys Ala Ser Pro Arg Gly Glu Arg Ser 35 40 45 Glu Pro Asp Ala Gln Lys His Asp Arg Arg Asp Val Leu Leu Gly Leu 50 55 60 Gly Ala Leu Gly Ala Ser Ala Thr Ala Thr Leu Ala Ser Ala Arg Arg 65 70 75 80 Ala Gly Ala Asp Pro Val Ala Thr Pro Asp Ile Ser Ser Cys Gly Gln 85 90 95 Ala Asn Leu Pro Val Ser Ala Asn Val Leu Thr Cys Cys Pro Pro Pro 100 105 110 Ser Ser Ala Leu Pro Val Asp Phe Ile Leu Pro Asp Ala Thr Ser Leu 115 120 125 Pro Leu Arg Thr Arg Pro Ala Ala His Ser Val Thr Thr Asp Tyr Val 130 135 140 Ala Lys Val Gln Arg Arg 145 150 3 995 DNA Zea mays 3 gcacgaggga catggcctcc atttcgcatt taattgctaa gccagctcca gctgccacct 60 ttcctctatc ccttccgaga acgagctccg gcttcaggcc tcgccgcgtt accgtccagc 120 gcgtctcgtg cgcatctccc agaggcgaac gctccgagcc agacgcccaa aagcacgacc 180 gccgcgacgt cctcctcggc ctcggagcgc tcggtgccag tgccaccgct accctggcgt 240 ccgcgcgccg cgccggcgcc gaccccgtcg ccacgcccga catctcttcc tgcggccaag 300 cgaaccttcc ggtgagcgcc aacgtgctga cgtgctgccc gccgccctcg agcgcgctgc 360 ccgtggactt catcctcccc gacgccacgt ccttgccgct ccggacgcgc cccgccgcgc 420 actcggtcac cacggactac gtcgccaagt tcaacgccgg gatcgctgcg atgaaggcgc 480 tcccggcgga cgacccgcgt agcttcgcgg cgcaggcgag cgtgcactgc gcctactgcg 540 acgggtcgta cagccccgag gggttccccg gtgtggagct ccaggtgcac aactcgtggc 600 tctttttccc cttccaccgc tgctacctat acttcttcga gcgcatcctg ggcagcctga 660 tcggcgaccc cggcttcgcg gtaccgttct ggaactggga cgcgccggac gggatgcgca 720 tgccggccat gtacgcggac cggtcatccc agctgttcga tccgcggcgt gacagccggc 780 acgcgccgcc gaagctcatc aatctggact acaacgccaa cgttagggag ccgaggttca 840 cttactaaca acaggttgat cacaacctca gggtcatgta ccgtcaggta attaacaacg 900 tgtgtttaca tgctatgaag tatgaactgc cgaaaccaag tacatggtct tggaatcttg 960 ccaaaactga tcaaaaaaaa aaaaaaaaaa aaaaa 995 4 278 PRT Zea mays 4 Met Ala Ser Ile Ser His Leu Ile Ala Lys Pro Ala Pro Ala Ala Thr 1 5 10 15 Phe Pro Leu Ser Leu Pro Arg Thr Ser Ser Gly Phe Arg Pro Arg Arg 20 25 30 Val Thr Val Gln Arg Val Ser Cys Ala Ser Pro Arg Gly Glu Arg Ser 35 40 45 Glu Pro Asp Ala Gln Lys His Asp Arg Arg Asp Val Leu Leu Gly Leu 50 55 60 Gly Ala Leu Gly Ala Ser Ala Thr Ala Thr Leu Ala Ser Ala Arg Arg 65 70 75 80 Ala Gly Ala Asp Pro Val Ala Thr Pro Asp Ile Ser Ser Cys Gly Gln 85 90 95 Ala Asn Leu Pro Val Ser Ala Asn Val Leu Thr Cys Cys Pro Pro Pro 100 105 110 Ser Ser Ala Leu Pro Val Asp Phe Ile Leu Pro Asp Ala Thr Ser Leu 115 120 125 Pro Leu Arg Thr Arg Pro Ala Ala His Ser Val Thr Thr Asp Tyr Val 130 135 140 Ala Lys Phe Asn Ala Gly Ile Ala Ala Met Lys Ala Leu Pro Ala Asp 145 150 155 160 Asp Pro Arg Ser Phe Ala Ala Gln Ala Ser Val His Cys Ala Tyr Cys 165 170 175 Asp Gly Ser Tyr Ser Pro Glu Gly Phe Pro Gly Val Glu Leu Gln Val 180 185 190 His Asn Ser Trp Leu Phe Phe Pro Phe His Arg Cys Tyr Leu Tyr Phe 195 200 205 Phe Glu Arg Ile Leu Gly Ser Leu Ile Gly Asp Pro Gly Phe Ala Val 210 215 220 Pro Phe Trp Asn Trp Asp Ala Pro Asp Gly Met Arg Met Pro Ala Met 225 230 235 240 Tyr Ala Asp Arg Ser Ser Gln Leu Phe Asp Pro Arg Arg Asp Ser Arg 245 250 255 His Ala Pro Pro Lys Leu Ile Asn Leu Asp Tyr Asn Ala Asn Val Arg 260 265 270 Glu Pro Arg Phe Thr Tyr 275 5 403 DNA Zea mays unsure (347) n = a, c, g or t 5 ggaacggcct ccgccccggc aacagcgact tcaccgaccc cagctggctg gacgccagct 60 tcctcttcta cgacgaggag gcccgcctcg tccgcgtgcg cgtccgggac tgcctcgaca 120 ccgctgccct gggctacgcc taccaggacg tcgccctgcc gtggctgaac gccaagccgg 180 ccaaggaggc cgggtctccg gcgcccaccg cgggcgcgct cccggcgaca ctgaaccaga 240 ccgtgcgggt ggccgtgacg cggcccaaga cctcgaggac ccgcaaggag aaggacgcca 300 aggaagaagt gctggtcgtc caagggatcg aaatcgctga ccactcnaac angttcgtcn 360 agttcgactt gttcgtgaac gaatcccaaa acgggggcng nat 403 6 126 PRT Zea mays UNSURE (117) Xaa = any amino acid 6 Asn Gly Leu Arg Pro Gly Asn Ser Asp Phe Thr Asp Pro Ser Trp Leu 1 5 10 15 Asp Ala Ser Phe Leu Phe Tyr Asp Glu Glu Ala Arg Leu Val Arg Val 20 25 30 Arg Val Arg Asp Cys Leu Asp Thr Ala Ala Leu Gly Tyr Ala Tyr Gln 35 40 45 Asp Val Ala Leu Pro Trp Leu Asn Ala Lys Pro Ala Lys Glu Ala Gly 50 55 60 Ser Pro Ala Pro Thr Ala Gly Ala Leu Pro Ala Thr Leu Asn Gln Thr 65 70 75 80 Val Arg Val Ala Val Thr Arg Pro Lys Thr Ser Arg Thr Arg Lys Glu 85 90 95 Lys Asp Ala Lys Glu Glu Val Leu Val Val Gln Gly Ile Glu Ile Ala 100 105 110 Asp His Ser Asn Xaa Phe Val Xaa Phe Asp Leu Phe Val Asn 115 120 125 7 711 DNA Glycine max unsure (573) n = a, c, g or t 7 tttttttttt ttttttcatt ggacaaccaa cattattatt ataacattat ggagatgcag 60 atcatcatca tcccactagg gagtatactt tctcgtgccg aattcggcac ctcagtcatt 120 cgtgtctgca gtgtataatg ttccttccaa gtctaccact ctcccttctt ccctgcatcc 180 attttcacaa tcccaatcca ctaaatatag aaaatcaaaa caccatcaca ctcctagagt 240 gacatgtaat agtggaaacc aaaacaaagg agaaaaacca gatattcata tagaacaaag 300 gaggaacatt ctacttggcc taggagggct ttgtggtgct gctactctta acaacaaccc 360 ttttgcattt gctgcgccaa tatctcctcc aagacctaac acatgtggtc caccagacct 420 acctgaaggt gcagaaccca caaattgttg ccccccattt tcatccacca tcatagattt 480 caagtttcct ccttctaaca aacccttgcg tgtaagacca gctgcacatt tagttgacaa 540 aaattatcta gccaaataca aaaaagccat tgncctcatg aaaaattcca gctaacgatc 600 anctatttca tcaacaagca aacgtgcacg cgctatgcac tggttaaatg acaaattggg 660 tcctggccnt gagctcagtg caagctctgg cctcttccta cacgatggtc t 711 8 156 PRT Glycine max UNSURE (153) Xaa = any amino acid 8 Ser Phe Val Ser Ala Val Tyr Asn Val Pro Ser Lys Ser Thr Thr Leu 1 5 10 15 Pro Ser Ser Leu His Pro Phe Ser Gln Ser Gln Ser Thr Lys Tyr Arg 20 25 30 Lys Ser Lys His His His Thr Pro Arg Val Thr Cys Asn Ser Gly Asn 35 40 45 Gln Asn Lys Gly Glu Lys Pro Asp Ile His Ile Glu Gln Arg Arg Asn 50 55 60 Ile Leu Leu Gly Leu Gly Gly Leu Cys Gly Ala Ala Thr Leu Asn Asn 65 70 75 80 Asn Pro Phe Ala Phe Ala Ala Pro Ile Ser Pro Pro Arg Pro Asn Thr 85 90 95 Cys Gly Pro Pro Asp Leu Pro Glu Gly Ala Glu Pro Thr Asn Cys Cys 100 105 110 Pro Pro Phe Ser Ser Thr Ile Ile Asp Phe Lys Phe Pro Pro Ser Asn 115 120 125 Lys Pro Leu Arg Val Arg Pro Ala Ala His Leu Val Asp Lys Asn Tyr 130 135 140 Leu Ala Lys Tyr Lys Lys Ala Ile Xaa Leu Met Lys 145 150 155 9 2485 DNA Glycine max 9 gcacgagttt tttttttttt tttcattgga caaccaacat tattattata acattatgga 60 gatgcagatc atcatcatcc cactagggag tatactttct cgtgccgaat tcggcacctc 120 agtcattcgt gtctgcagtg tataatgttc cttccaagtc taccactctc ccttcttccc 180 tgcatccatt ttcacaatcc caatccacta aatatagaaa atcaaaacac catcacactc 240 ctagagtgac atgtaatagt ggaaaccaaa acaaaggaga aaaaccagat attcatatag 300 aacaaaggag gaacattcta cttggcctag gagggctttg tggtgctgct actcttaaca 360 acaacccttt tgcatttgct gcgccaatat ctcctccaga cctaaccaca tgtggtccac 420 cagacctacc tgaaggtgca gaacccacaa attgttgccc cccattttca tccaccatca 480 tagatttcaa gtttcctcct tctaacaaac ctttgcgtgt aagaccagct gcacatttag 540 ttgacaaaaa ttatctagcc aaatacaaaa aagccattga cctcatgaaa aaactcccag 600 ctaacgatcc acgcaatttc atgcaacaag caaacgtgca ctgcgcttat tgcactggtt 660 catatgacca agttgggttc cctggccttg agctccaagt gcacagctct tggctcttct 720 ttccctacca ccgatggttc ctctatttct atgagagaat tttggggagc ttgatcaatg 780 atccaacatt tgcccttcca ttttggaact gggatgctcc taagggcatg caacttcctt 840 ccatttatgc agaccccaaa tcacctcttt atgaccctct tcgcaatgcg aatcaccaac 900 ctccaacact tgtggacttt gacttcaatc ttgacaatcc tatttccaat ggaagaatct 960 ccaccaacct caccataatg tataggcaac ttgtgtctaa tggaaaaact cctactttgt 1020 tccttggaaa tccttatcgt gccggggatg cgcctgaccc tggcggtggc tcagtagagg 1080 gcgttccaca tggtccggtt catctatgga caggtgatat aaatcaacca aacattgaga 1140 acatggggga tttctattct gctgcaagag atcctatttt ctattctcac cattccaatg 1200 ttgataggat gtggtctata tggaaaacac ttggtgggaa gagaagggat ttcaccgact 1260 cagattggtt ggaatctggg ctcctcttct acgatgagaa taagaacctt gtgcgtgtga 1320 aggtcaagga ttgtcttgac acaagaaagc taggatatgt ttaccaagat gttgaaattc 1380 catggttaaa atctaagcct tcaccgcgta ggtcgagggt tcaaaaggta gcactaggac 1440 cacattttaa tactggtgta gcacgtgctg ctgagacttc gaggaatgtt cagttcccat 1500 tggtgttgga ttcagttgtg agcatagtgg tgaagaggcc aaaaaagtcg aggagcaaga 1560 aggagaagga agaggaagag gaggttcttg tgattgaagg ggttgagtat gacagcaaca 1620 taccagtgaa atttgatgtg cttattaatg atgaagatga taagcagatt cagccagaag 1680 attcggagta tgcaggaagc tttgtgactg tgcctcattc gcataagcac aaaaataaga 1740 agattatcac ttgtttgagg ctgggactga cagatttgtt ggaagaattg gaagcagaag 1800 atgatgatag tgttgtggtg acgttggttc cgaggtatgg gaaagggcgt gtccaaattg 1860 gaggcatcaa gatagatctt gttgcagatt aaaaaatatt tatatacttc gactgtttaa 1920 cctcataata atatatatat atatatatat aatgtagttt cttggatttg tgtttgcttt 1980 tatatgaaaa atgtagtttt tgttatgtat tttccatgag aatcataaga atgtcgctaa 2040 ttgaagtgaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa 2100 aaaaaaaacc cccggggggg ggccgggaac aaaatccccc aaaaagagag tcataaaacg 2160 cgcgcacagg ggccgtcttt taaaaacctc gaaagggaaa aaacccgggc gaaacaaaat 2220 aaaaaccctt taaaaaaaac ccccctttcc aaaaggggaa aaaaaaaaaa aaggcccaca 2280 acaatccccc tccaaaaaaa tttgcccacc caaaagggaa aaggagaccc cccctgtagc 2340 ggcaaaaaaa ccgggggggg tgtgggggat acccaaatgt aaccgaaaaa tttgaaaacc 2400 ccaaagcccc cgcccctttc cttttctccc cttcctttcc ccaaatttcc cgggtttccc 2460 ccgaaaaacc aaaaaacggg ggccc 2485 10 601 PRT Glycine max 10 Gly Val Tyr Phe Leu Val Pro Asn Ser Ala Pro Gln Ser Phe Val Ser 1 5 10 15 Ala Val Tyr Asn Val Pro Ser Lys Ser Thr Thr Leu Pro Ser Ser Leu 20 25 30 His Pro Phe Ser Gln Ser Gln Ser Thr Lys Tyr Arg Lys Ser Lys His 35 40 45 His His Thr Pro Arg Val Thr Cys Asn Ser Gly Asn Gln Asn Lys Gly 50 55 60 Glu Lys Pro Asp Ile His Ile Glu Gln Arg Arg Asn Ile Leu Leu Gly 65 70 75 80 Leu Gly Gly Leu Cys Gly Ala Ala Thr Leu Asn Asn Asn Pro Phe Ala 85 90 95 Phe Ala Ala Pro Ile Ser Pro Pro Asp Leu Thr Thr Cys Gly Pro Pro 100 105 110 Asp Leu Pro Glu Gly Ala Glu Pro Thr Asn Cys Cys Pro Pro Phe Ser 115 120 125 Ser Thr Ile Ile Asp Phe Lys Phe Pro Pro Ser Asn Lys Pro Leu Arg 130 135 140 Val Arg Pro Ala Ala His Leu Val Asp Lys Asn Tyr Leu Ala Lys Tyr 145 150 155 160 Lys Lys Ala Ile Asp Leu Met Lys Lys Leu Pro Ala Asn Asp Pro Arg 165 170 175 Asn Phe Met Gln Gln Ala Asn Val His Cys Ala Tyr Cys Thr Gly Ser 180 185 190 Tyr Asp Gln Val Gly Phe Pro Gly Leu Glu Leu Gln Val His Ser Ser 195 200 205 Trp Leu Phe Phe Pro Tyr His Arg Trp Phe Leu Tyr Phe Tyr Glu Arg 210 215 220 Ile Leu Gly Ser Leu Ile Asn Asp Pro Thr Phe Ala Leu Pro Phe Trp 225 230 235 240 Asn Trp Asp Ala Pro Lys Gly Met Gln Leu Pro Ser Ile Tyr Ala Asp 245 250 255 Pro Lys Ser Pro Leu Tyr Asp Pro Leu Arg Asn Ala Asn His Gln Pro 260 265 270 Pro Thr Leu Val Asp Phe Asp Phe Asn Leu Asp Asn Pro Ile Ser Asn 275 280 285 Gly Arg Ile Ser Thr Asn Leu Thr Ile Met Tyr Arg Gln Leu Val Ser 290 295 300 Asn Gly Lys Thr Pro Thr Leu Phe Leu Gly Asn Pro Tyr Arg Ala Gly 305 310 315 320 Asp Ala Pro Asp Pro Gly Gly Gly Ser Val Glu Gly Val Pro His Gly 325 330 335 Pro Val His Leu Trp Thr Gly Asp Ile Asn Gln Pro Asn Ile Glu Asn 340 345 350 Met Gly Asp Phe Tyr Ser Ala Ala Arg Asp Pro Ile Phe Tyr Ser His 355 360 365 His Ser Asn Val Asp Arg Met Trp Ser Ile Trp Lys Thr Leu Gly Gly 370 375 380 Lys Arg Arg Asp Phe Thr Asp Ser Asp Trp Leu Glu Ser Gly Leu Leu 385 390 395 400 Phe Tyr Asp Glu Asn Lys Asn Leu Val Arg Val Lys Val Lys Asp Cys 405 410 415 Leu Asp Thr Arg Lys Leu Gly Tyr Val Tyr Gln Asp Val Glu Ile Pro 420 425 430 Trp Leu Lys Ser Lys Pro Ser Pro Arg Arg Ser Arg Val Gln Lys Val 435 440 445 Ala Leu Gly Pro His Phe Asn Thr Gly Val Ala Arg Ala Ala Glu Thr 450 455 460 Ser Arg Asn Val Gln Phe Pro Leu Val Leu Asp Ser Val Val Ser Ile 465 470 475 480 Val Val Lys Arg Pro Lys Lys Ser Arg Ser Lys Lys Glu Lys Glu Glu 485 490 495 Glu Glu Glu Val Leu Val Ile Glu Gly Val Glu Tyr Asp Ser Asn Ile 500 505 510 Pro Val Lys Phe Asp Val Leu Ile Asn Asp Glu Asp Asp Lys Gln Ile 515 520 525 Gln Pro Glu Asp Ser Glu Tyr Ala Gly Ser Phe Val Thr Val Pro His 530 535 540 Ser His Lys His Lys Asn Lys Lys Ile Ile Thr Cys Leu Arg Leu Gly 545 550 555 560 Leu Thr Asp Leu Leu Glu Glu Leu Glu Ala Glu Asp Asp Asp Ser Val 565 570 575 Val Val Thr Leu Val Pro Arg Tyr Gly Lys Gly Arg Val Gln Ile Gly 580 585 590 Gly Ile Lys Ile Asp Leu Val Ala Asp 595 600 11 450 DNA Triticum aestivum unsure (20) n = a, c, g or t 11 ctggtgccga attcggcacn agaccatttt acctcctcga gttcaccatg gagatcagca 60 cgagcgtggc aaggtgcact cgcatgccgt gcagcctcca agccctcgtg cccacgaagg 120 cgaggcagac gcggcgcctg acgtgcaagg caaccggcgg ccgcgtcgac cgccgcgacg 180 tgctcctcgg cctcggcagc gccgcggcgg ccgggctggg cgcgcagcgg ggccgagggg 240 cgattgccgc gcccatccag gccccggacc tcggcaactg caacccgccc gacctcccga 300 acacggcgcc tgacaacaac tgctgcccga cgtccggcac cggcatcatc gacttcntgt 360 gccgccggct cctcgggcgc cgctccgcnt gcgcccggcc gcgcactggg anacgcggag 420 tactggccaa gtacaacggc cgtnggctaa 450 12 166 PRT Triticum aestivum UNSURE (163) Xaa = any amino acid 12 Met Glu Ile Ser Thr Ser Val Ala Arg Cys Thr Arg Met Pro Cys Ser 1 5 10 15 Leu Gln Ala Leu Val Pro Thr Lys Ala Arg Gln Thr Arg Arg Leu Thr 20 25 30 Cys Lys Ala Thr Gly Gly Arg Val Asp Arg Arg Asp Val Leu Leu Gly 35 40 45 Leu Gly Ser Ala Ala Ala Ala Gly Leu Gly Ala Gln Arg Gly Arg Gly 50 55 60 Ala Ile Ala Ala Pro Ile Gln Ala Pro Asp Leu Gly Asn Cys Asn Pro 65 70 75 80 Pro Asp Leu Pro Asn Thr Ala Pro Asp Thr Asn Cys Cys Pro Thr Ser 85 90 95 Gly Thr Gly Ile Ile Asp Phe Val Leu Pro Pro Ala Pro Arg Ala Pro 100 105 110 Leu Arg Val Arg Pro Ala Ala His Leu Ala Asp Ala Glu Tyr Leu Ala 115 120 125 Lys Tyr Glu Arg Ala Val Ala Leu Met Lys Gln Leu Pro Ala Asp Asp 130 135 140 Pro Arg Ser Ser Lys Gln Gln Trp Arg Val His Cys Ala Tyr Cys Glu 145 150 155 160 Arg Pro Xaa Arg Gln Val 165 13 1993 DNA Triticum aestivum 13 ctggtgccga attcggcacg agaccatttt acctcctcga gttcaccatg gagatcagca 60 cgagcgtggc aaggtgcact cgcatgccgt gcagcctcca agccctcgtg cccacgaagg 120 cgaggcagac gcggcgcctg acgtgcaagg caaccggcgg ccgcgtcgac cgccgcgacg 180 tgctcctcgg cctcggcagc gccgcggcgg ccgggctggg cgcgcagcgg gcccgagggg 240 cgattgccgc gcccatccag gccccggacc tcggcaactg caacccgccc gacctcccga 300 acacggcgcc tgacaccaac tgctgcccga cgtccggcac cggcatcatc gacttcgtgc 360 tgccgccggc ctcctcggcg ccgctccgcg tgcgcccggc cgcgcacctg gcagacgcgg 420 agtacctggc caagtacgag cgggccgtgg cgctcatgaa gcagctgccc gccgacgacc 480 cgcgcagctt cgagcagcag tggcgcgtgc actgcgccta ctgcgacggc gcctacgacc 540 aggtcggctt cccggacctg gagatccagg tgcacaactg ctggctcttc ttcccatggc 600 acaggttcta cctctacttc cacgagcgga tcctcggcaa gctcatcggc gacgacacct 660 tcgcgctgcc cttctggaac tgggacgcgc cggacggcat gacgctgccg gcgatctacg 720 ccaacaggtc gtcgccgctc tacaacgaga ggcgcaaccc cgcccaccag ccgccgttcc 780 cggtcgacct cgacttcaac gagatagatg tcatcatccc aacagacgag cagatcgacc 840 agaacctcaa catcatgtac cgccagatgg tgtcgggtgc caagaagact cggctgttca 900 tggggcagcc gtaccgcgcc ggcgaccagc cggaccctgg cgcgggctcc gtggagaacg 960 tgccgcacgg cacgatgcac acctggacgg gcgacccggc gcaacccaac aacgaggaca 1020 tgggcaactt ctactcggcg gcgcgcgacc ccatcttctt cgcgcaccac ggcaacatcg 1080 accgcctctg gcacgtctgg cgcggcctcc gccccggcaa cgccgacttc accgacactg 1140 actggcttga caccgccttc ctcttctacg acgaggaggc ccgccccgtg cgcgtccgcg 1200 tccgcgactg cctcgacccg gccgccatgg ggtacgcgta ccaggacgtc ggcctgccgt 1260 ggctgaaagc caagccggcc aagagatccc gcaggacgcc ggcgcccgcc gcgggcgcgc 1320 tcccggcgac gctgagggag accgtgcggg tgacggtgac aaggccccag gtgtcgagga 1380 gcgacaagga gaaggaggag gcggaggagg tgctgatcgt cgaggggatc caggtcgccg 1440 accacttcaa gttcgtcaag ttcgacgtgc tggtgaacgc gcccgagagc ggaggcgatg 1500 ccgcgtcggg gtactgcgcc ggcagcgtcg cgatgacgcc gcacatggtc cggacgaaca 1560 agaagaaggg ctccgtgaag acggtggcga ggttcggcgt ctgcgacctg atggacaaca 1620 tcggggcaga cggcgacaag acggtggtcg tgtcgcttgt gcccaggtgc ggcggcgagc 1680 tggtcaccat cggcggcgtc agcatcggct ataccaagtg aagcaccgcc accgtatata 1740 ccgtgtggtg tatatctaaa caagtcgctc atgagcgatc gttgcgtgct ttacgtcacg 1800 tatgtctagc gtatattgcg ccgtatgtta cgtgcatcta ctgtgcttat attgcagcgt 1860 atgtctagcg tattctaata agaacaattg gaacggtgca ctttattgtc cttacttcat 1920 atatagtact catgttacaa gtacattaaa aaaaaaaaaa aaaaaaaaaa aaaaaaaaaa 1980 aaaaaaaaaa aaa 1993 14 557 PRT Triticum aestivum 14 Met Glu Ile Ser Thr Ser Val Ala Arg Cys Thr Arg Met Pro Cys Ser 1 5 10 15 Leu Gln Ala Leu Val Pro Thr Lys Ala Arg Gln Thr Arg Arg Leu Thr 20 25 30 Cys Lys Ala Thr Gly Gly Arg Val Asp Arg Arg Asp Val Leu Leu Gly 35 40 45 Leu Gly Ser Ala Ala Ala Ala Gly Leu Gly Ala Gln Arg Ala Arg Gly 50 55 60 Ala Ile Ala Ala Pro Ile Gln Ala Pro Asp Leu Gly Asn Cys Asn Pro 65 70 75 80 Pro Asp Leu Pro Asn Thr Ala Pro Asp Thr Asn Cys Cys Pro Thr Ser 85 90 95 Gly Thr Gly Ile Ile Asp Phe Val Leu Pro Pro Ala Ser Ser Ala Pro 100 105 110 Leu Arg Val Arg Pro Ala Ala His Leu Ala Asp Ala Glu Tyr Leu Ala 115 120 125 Lys Tyr Glu Arg Ala Val Ala Leu Met Lys Gln Leu Pro Ala Asp Asp 130 135 140 Pro Arg Ser Phe Glu Gln Gln Trp Arg Val His Cys Ala Tyr Cys Asp 145 150 155 160 Gly Ala Tyr Asp Gln Val Gly Phe Pro Asp Leu Glu Ile Gln Val His 165 170 175 Asn Cys Trp Leu Phe Phe Pro Trp His Arg Phe Tyr Leu Tyr Phe His 180 185 190 Glu Arg Ile Leu Gly Lys Leu Ile Gly Asp Asp Thr Phe Ala Leu Pro 195 200 205 Phe Trp Asn Trp Asp Ala Pro Asp Gly Met Thr Leu Pro Ala Ile Tyr 210 215 220 Ala Asn Arg Ser Ser Pro Leu Tyr Asn Glu Arg Arg Asn Pro Ala His 225 230 235 240 Gln Pro Pro Phe Pro Val Asp Leu Asp Phe Asn Glu Ile Asp Val Ile 245 250 255 Ile Pro Thr Asp Glu Gln Ile Asp Gln Asn Leu Asn Ile Met Tyr Arg 260 265 270 Gln Met Val Ser Gly Ala Lys Lys Thr Arg Leu Phe Met Gly Gln Pro 275 280 285 Tyr Arg Ala Gly Asp Gln Pro Asp Pro Gly Ala Gly Ser Val Glu Asn 290 295 300 Val Pro His Gly Thr Met His Thr Trp Thr Gly Asp Pro Ala Gln Pro 305 310 315 320 Asn Asn Glu Asp Met Gly Asn Phe Tyr Ser Ala Ala Arg Asp Pro Ile 325 330 335 Phe Phe Ala His His Gly Asn Ile Asp Arg Leu Trp His Val Trp Arg 340 345 350 Gly Leu Arg Pro Gly Asn Ala Asp Phe Thr Asp Thr Asp Trp Leu Asp 355 360 365 Thr Ala Phe Leu Phe Tyr Asp Glu Glu Ala Arg Pro Val Arg Val Arg 370 375 380 Val Arg Asp Cys Leu Asp Pro Ala Ala Met Gly Tyr Ala Tyr Gln Asp 385 390 395 400 Val Gly Leu Pro Trp Leu Lys Ala Lys Pro Ala Lys Arg Ser Arg Arg 405 410 415 Thr Pro Ala Pro Ala Ala Gly Ala Leu Pro Ala Thr Leu Arg Glu Thr 420 425 430 Val Arg Val Thr Val Thr Arg Pro Gln Val Ser Arg Ser Asp Lys Glu 435 440 445 Lys Glu Glu Ala Glu Glu Val Leu Ile Val Glu Gly Ile Gln Val Ala 450 455 460 Asp His Phe Lys Phe Val Lys Phe Asp Val Leu Val Asn Ala Pro Glu 465 470 475 480 Ser Gly Gly Asp Ala Ala Ser Gly Tyr Cys Ala Gly Ser Val Ala Met 485 490 495 Thr Pro His Met Val Arg Thr Asn Lys Lys Lys Gly Ser Val Lys Thr 500 505 510 Val Ala Arg Phe Gly Val Cys Asp Leu Met Asp Asn Ile Gly Ala Asp 515 520 525 Gly Asp Lys Thr Val Val Val Ser Leu Val Pro Arg Cys Gly Gly Glu 530 535 540 Leu Val Thr Ile Gly Gly Val Ser Ile Gly Tyr Thr Lys 545 550 555 15 852 DNA Glycine max unsure (390) n = a, c, g or t 15 cccctctgat gacccgcgta atttcaccca acaagccaac gttcattgtg cttattgtga 60 tggtgcatat caccaagttg ggttccctga cctcgatctc caagtccaca actcctggct 120 cttcttccct ttccatcgtt ggtatcttta tttctatgaa aggatcttgg ggagcttgat 180 caatgatcca acctttgccc ttccattttg gaactgggat gctcctaagg gcatgcaact 240 tccttccatt tacgcagacc ctaaatcacc cctttatgac actctccgca atgccaatca 300 tcaaccccca acactcgtag acctcgactt caatctcgag gatcctattt ccaatggcaa 360 aatttccaac aacctcacca taatgtatan gcaagttgtg tctaacggga agactcctac 420 attgttcctt ggaaatcctt accgtgctgg ggatgagcct gacccgggtt ttggatcagt 480 agagaatgtt ccacatggcc ctgttcatct ttggnccggt gatatcaacc aacctaacat 540 tgngaacatg ggaactttct attcagctgc aggagacccc attttttatt ctcatcattc 600 agacattgat aagatgtggt ccatatggaa aacactttgt gggaaaagaa gggattttac 660 tgattcantt gggtaaaatc tgcgttctct tctacgatga taacaagaac cttgtgcntn 720 tnaaggcaag gatctcntga cactanaaac taggtatgtt tacaagattt gacatccatg 780 gttaattcta nccacccgnt tagtcagggt aaaaggacat tanacaaatt tgtgtgggga 840 ncatcgcnaa ct 852 16 221 PRT Glycine max UNSURE (130) Xaa = any amino acid 16 Pro Ser Asp Asp Pro Arg Asn Phe Thr Gln Gln Ala Asn Val His Cys 1 5 10 15 Ala Tyr Cys Asp Gly Ala Tyr His Gln Val Gly Phe Pro Asp Leu Asp 20 25 30 Leu Gln Val His Asn Ser Trp Leu Phe Phe Pro Phe His Arg Trp Tyr 35 40 45 Leu Tyr Phe Tyr Glu Arg Ile Leu Gly Ser Leu Ile Asn Asp Pro Thr 50 55 60 Phe Ala Leu Pro Phe Trp Asn Trp Asp Ala Pro Lys Gly Met Gln Leu 65 70 75 80 Pro Ser Ile Tyr Ala Asp Pro Lys Ser Pro Leu Tyr Asp Thr Leu Arg 85 90 95 Asn Ala Asn His Gln Pro Pro Thr Leu Val Asp Leu Asp Phe Asn Leu 100 105 110 Glu Asp Pro Ile Ser Asn Gly Lys Ile Ser Asn Asn Leu Thr Ile Met 115 120 125 Tyr Xaa Gln Val Val Ser Asn Gly Lys Thr Pro Thr Leu Phe Leu Gly 130 135 140 Asn Pro Tyr Arg Ala Gly Asp Glu Pro Asp Pro Gly Phe Gly Ser Val 145 150 155 160 Glu Asn Val Pro His Gly Pro Val His Leu Trp Xaa Gly Asp Ile Asn 165 170 175 Gln Pro Asn Ile Xaa Asn Met Gly Thr Phe Tyr Ser Ala Ala Gly Asp 180 185 190 Pro Ile Phe Tyr Ser His His Ser Asp Ile Asp Lys Met Trp Ser Ile 195 200 205 Trp Lys Thr Leu Cys Gly Lys Arg Arg Asp Phe Thr Asp 210 215 220 17 522 DNA Glycine max 17 atctctcctc tatccttcgt gcccacagtc aataatgtct cttccaactc catcgctccc 60 ccttctccgt tgcatccatt ttcacgattc caatccatta aaaatagaaa gccaaaaccc 120 catcatattc ctagaatcac atgcagtgga aaccaaaaca atccaacacc aaaccctaat 180 tcccagggag aacctccaca tattgtagga cataggagga acgttctact tggcctagga 240 gggctttgtg gtgctgttac tcttaacaac aacaaccctt ttgcctttgc agctccaata 300 tctcctcctg acctaaacac gtgcggtcca ccagacctac ccgcaggtgt aaaacccacc 360 aattgttgcc ccccatcttc caaaatcata gatttcaagt tctctccctc taaccaaccc 420 ttgagggtaa gaccagccgc acatttggtc aacgatgagt atctagccaa atacaaaaaa 480 agccttgacc tcatgaaaaa actcccctct gatgaccggg tt 522 18 174 PRT Glycine max 18 Ile Ser Pro Leu Ser Phe Val Pro Thr Val Asn Asn Val Ser Ser Asn 1 5 10 15 Ser Ile Ala Pro Pro Ser Pro Leu His Pro Phe Ser Arg Phe Gln Ser 20 25 30 Ile Lys Asn Arg Lys Pro Lys Pro His His Ile Pro Arg Ile Thr Cys 35 40 45 Ser Gly Asn Gln Asn Asn Pro Thr Pro Asn Pro Asn Ser Gln Gly Glu 50 55 60 Pro Pro His Ile Val Gly His Arg Arg Asn Val Leu Leu Gly Leu Gly 65 70 75 80 Gly Leu Cys Gly Ala Val Thr Leu Asn Asn Asn Asn Pro Phe Ala Phe 85 90 95 Ala Ala Pro Ile Ser Pro Pro Asp Leu Asn Thr Cys Gly Pro Pro Asp 100 105 110 Leu Pro Ala Gly Val Lys Pro Thr Asn Cys Cys Pro Pro Ser Ser Lys 115 120 125 Ile Ile Asp Phe Lys Phe Ser Pro Ser Asn Gln Pro Leu Arg Val Arg 130 135 140 Pro Ala Ala His Leu Val Asn Asp Glu Tyr Leu Ala Lys Tyr Lys Lys 145 150 155 160 Ser Leu Asp Leu Met Lys Lys Leu Pro Ser Asp Asp Arg Val 165 170 19 1989 DNA Glycine max 19 gcacgagatc tctcctctat ccttcgtgcc cacagtcaat aatgtctctt ccaactccat 60 cgctccccct tctccgttgc atccattttc acgattccaa tccattaaaa atagaaagcc 120 aaaaccccat catattccta gaatcacatg cagtggaaac caaaacaatc caacaccaaa 180 ccctaattcc cagggagaac ctccacatat tgtaggacat aggaggaacg ttctacttgg 240 cctaggaggg ctttgtggtg ctgttactct taacaacaac aacccttttg cctttgcagc 300 tccaatatct cctcctgacc taaacacgtg cggtccacca gacctacccg caggtgtaaa 360 acccaccaat tgttgccccc catcttccaa aatcatagat ttcaagttct ctccctctaa 420 ccaacccttg agggtaagac cagccgcaca tttggtcaac gatgagtatc tagccaaata 480 caaaaaagcc cttgacctca tgaaaaaact cccctctgat gacccgcgta atttcaccca 540 acaagccaac gttcattgtg cttattgtga tggtgcatat caccaagttg ggttccctga 600 cctcgatctc caagtccaca actcctggct cttcttccct ttccatcgtt ggtatcttta 660 tttctatgaa aggatcttgg ggagcttgat caatgatcca acctttgccc ttccattttg 720 gaactgggat gctcctaagg gcatgcaact tccttccatt tacgcagacc ctaaatcacc 780 cctttatgac actctccgca atgccaatca tcaaccccca acactcgtag acctcgactt 840 caatctcgag gatcctattt ccaatggcaa aatttccaac aacctcacca taatgtatag 900 gcaagttgtg tctaacggga agactcctac attgttcctt ggaaatcctt accgtgctgg 960 ggatgagcct gacccgggtt ttggatcagt agagaatgtt ccacatggcc ctgttcatct 1020 ttggaccggt gatatcaacc aacctaacat tgagaacatg ggaactttct attcagctgc 1080 aagagacccc attttttatt ctcatcattc aaacattgat aggatgtggt ccatatggaa 1140 aacacttggt gggaaaagaa gggattttac tgattcagat tggttagaat ctgcgtttct 1200 cttctacgat gagaacaaga accttgtgcg tgtgaaggtc aaggattctc ttgacactag 1260 aaaactaggg tatgtttacc aagatgttga cattccatgg ttaaattcta agcccacgcc 1320 gcgtaggtca agggttcaga aggtagcatt agcacaaaat tttggtgttg gtgcagcaca 1380 tgctgctgag acttcaagga atgtgaagtt cccactagtg ttggattcag ttgtgagcac 1440 aatggttaaa aggccaaaca agtcgaggag caagaaggag aaggaagagg aggaagaggt 1500 tttggtgatt gaagggattg agtttgagag aaacacacct gtgaaatttg atgtgtttat 1560 caatgatgaa gatgataagc agattcgacc agataataca gaatttgcag gaagctttgt 1620 gagtgtgcct cattcacata tgcacaaaaa caaggacatc attacttgtt tgaggctggg 1680 acttacggat ttgttggaag aattggaagc ggaagatgat gacagtgtta gggtgacgct 1740 ggttccgaga tatgggaaag ggcgtgttaa aatcagaggc atcaaaatag agcttctttc 1800 ggattgaaaa ttatctatat gcttcaacta cttatatatg tgtgtgtggt aatacatata 1860 tggttactag tttccaataa agtgtgtaac tcataaagag atattatgta tttcctatca 1920 tatgctgatt catttaatac ttgataaata aaataaaaga ttaatgcgta aaaaaaaaaa 1980 aaaaaaaaa 1989 20 599 PRT Glycine max 20 Ile Ser Pro Leu Ser Phe Val Pro Thr Val Asn Asn Val Ser Ser Asn 1 5 10 15 Ser Ile Ala Pro Pro Ser Pro Leu His Pro Phe Ser Arg Phe Gln Ser 20 25 30 Ile Lys Asn Arg Lys Pro Lys Pro His His Ile Pro Arg Ile Thr Cys 35 40 45 Ser Gly Asn Gln Asn Asn Pro Thr Pro Asn Pro Asn Ser Gln Gly Glu 50 55 60 Pro Pro His Ile Val Gly His Arg Arg Asn Val Leu Leu Gly Leu Gly 65 70 75 80 Gly Leu Cys Gly Ala Val Thr Leu Asn Asn Asn Asn Pro Phe Ala Phe 85 90 95 Ala Ala Pro Ile Ser Pro Pro Asp Leu Asn Thr Cys Gly Pro Pro Asp 100 105 110 Leu Pro Ala Gly Val Lys Pro Thr Asn Cys Cys Pro Pro Ser Ser Lys 115 120 125 Ile Ile Asp Phe Lys Phe Ser Pro Ser Asn Gln Pro Leu Arg Val Arg 130 135 140 Pro Ala Ala His Leu Val Asn Asp Glu Tyr Leu Ala Lys Tyr Lys Lys 145 150 155 160 Ala Leu Asp Leu Met Lys Lys Leu Pro Ser Asp Asp Pro Arg Asn Phe 165 170 175 Thr Gln Gln Ala Asn Val His Cys Ala Tyr Cys Asp Gly Ala Tyr His 180 185 190 Gln Val Gly Phe Pro Asp Leu Asp Leu Gln Val His Asn Ser Trp Leu 195 200 205 Phe Phe Pro Phe His Arg Trp Tyr Leu Tyr Phe Tyr Glu Arg Ile Leu 210 215 220 Gly Ser Leu Ile Asn Asp Pro Thr Phe Ala Leu Pro Phe Trp Asn Trp 225 230 235 240 Asp Ala Pro Lys Gly Met Gln Leu Pro Ser Ile Tyr Ala Asp Pro Lys 245 250 255 Ser Pro Leu Tyr Asp Thr Leu Arg Asn Ala Asn His Gln Pro Pro Thr 260 265 270 Leu Val Asp Leu Asp Phe Asn Leu Glu Asp Pro Ile Ser Asn Gly Lys 275 280 285 Ile Ser Asn Asn Leu Thr Ile Met Tyr Arg Gln Val Val Ser Asn Gly 290 295 300 Lys Thr Pro Thr Leu Phe Leu Gly Asn Pro Tyr Arg Ala Gly Asp Glu 305 310 315 320 Pro Asp Pro Gly Phe Gly Ser Val Glu Asn Val Pro His Gly Pro Val 325 330 335 His Leu Trp Thr Gly Asp Ile Asn Gln Pro Asn Ile Glu Asn Met Gly 340 345 350 Thr Phe Tyr Ser Ala Ala Arg Asp Pro Ile Phe Tyr Ser His His Ser 355 360 365 Asn Ile Asp Arg Met Trp Ser Ile Trp Lys Thr Leu Gly Gly Lys Arg 370 375 380 Arg Asp Phe Thr Asp Ser Asp Trp Leu Glu Ser Ala Phe Leu Phe Tyr 385 390 395 400 Asp Glu Asn Lys Asn Leu Val Arg Val Lys Val Lys Asp Ser Leu Asp 405 410 415 Thr Arg Lys Leu Gly Tyr Val Tyr Gln Asp Val Asp Ile Pro Trp Leu 420 425 430 Asn Ser Lys Pro Thr Pro Arg Arg Ser Arg Val Gln Lys Val Ala Leu 435 440 445 Ala Gln Asn Phe Gly Val Gly Ala Ala His Ala Ala Glu Thr Ser Arg 450 455 460 Asn Val Lys Phe Pro Leu Val Leu Asp Ser Val Val Ser Thr Met Val 465 470 475 480 Lys Arg Pro Asn Lys Ser Arg Ser Lys Lys Glu Lys Glu Glu Glu Glu 485 490 495 Glu Val Leu Val Ile Glu Gly Ile Glu Phe Glu Arg Asn Thr Pro Val 500 505 510 Lys Phe Asp Val Phe Ile Asn Asp Glu Asp Asp Lys Gln Ile Arg Pro 515 520 525 Asp Asn Thr Glu Phe Ala Gly Ser Phe Val Ser Val Pro His Ser His 530 535 540 Met His Lys Asn Lys Asp Ile Ile Thr Cys Leu Arg Leu Gly Leu Thr 545 550 555 560 Asp Leu Leu Glu Glu Leu Glu Ala Glu Asp Asp Asp Ser Val Arg Val 565 570 575 Thr Leu Val Pro Arg Tyr Gly Lys Gly Arg Val Lys Ile Arg Gly Ile 580 585 590 Lys Ile Glu Leu Leu Ser Asp 595 21 887 DNA Glycine max unsure (33) n = a, c, g or t 21 cgacccgatt tttttttctc acccattcta acnttgttag gatgtggtcc catatgaaan 60 cgcttgttgg aaaaggaaag gattttactg actcggattg gttagaatct gggtttctct 120 tctacgatga gaataagaac cttgtgcgag taaaggttaa agattgtctt gacgagagaa 180 aactagggta tgtttaccaa gatgtagaca ttccatggtt aaactctagg cccacaccgc 240 gaaggtctag ggttcaaaag gttgcactag cacaaaattt tggtgttggt gcagcacgtg 300 ctgctgagac ttcaaggaat gtgaagttcc cactagtgtt ggattcagtt gtgagcacaa 360 tggttaaaag gccaaacaag tcgaggagca agaaggagaa ggaagaggag gaagaggttt 420 tggtgattga agggattgag tttgagagaa acacacctgt gaaatttgat gtgtttatca 480 atgatgaaga tgataagcag attcgaccag ataatacaga atttgcagga agctttgtga 540 gtgtgcctca ttcacatatg cacaaaaaca aggacatcat tacttgtttg aggctgggac 600 ttacggattt gttggaanga attggaagcg gaagatgatg acagtgttag ggtgacgctg 660 gttccgagat atgggaaagg gcgtgttaaa atcaagaggc atcaaaatag agcttctttc 720 ggattgaaaa ttatctatat gcttcaacta cttatatatg tgtgtgtggt aatacatata 780 tggttactaa gnttccaata aagtgtgtaa ctcataaaga gatattatgt atttcctatc 840 atatgctgat tcanttaata ctganaaata actaaaagat tatgctt 887 22 265 PRT Glycine max UNSURE (11) Xaa = any amino acid 22 Asp Pro Ile Phe Phe Ser His His Ser Asn Xaa Val Arg Met Trp Ser 1 5 10 15 His Met Lys Xaa Leu Val Gly Lys Gly Lys Asp Phe Thr Asp Ser Asp 20 25 30 Trp Leu Glu Ser Gly Phe Leu Phe Tyr Asp Glu Asn Lys Asn Leu Val 35 40 45 Arg Val Lys Val Lys Asp Cys Leu Asp Glu Arg Lys Leu Gly Tyr Val 50 55 60 Tyr Gln Asp Val Asp Ile Pro Trp Leu Asn Ser Arg Pro Thr Pro Arg 65 70 75 80 Arg Ser Arg Val Gln Lys Val Ala Leu Ala Gln Asn Phe Gly Val Gly 85 90 95 Ala Ala Arg Ala Ala Glu Thr Ser Arg Asn Val Lys Phe Pro Leu Val 100 105 110 Leu Asp Ser Val Val Ser Thr Met Val Lys Arg Pro Asn Lys Ser Arg 115 120 125 Ser Lys Lys Glu Lys Glu Glu Glu Glu Glu Val Leu Val Ile Glu Gly 130 135 140 Ile Glu Phe Glu Arg Asn Thr Pro Val Lys Phe Asp Val Phe Ile Asn 145 150 155 160 Asp Glu Asp Asp Lys Gln Ile Arg Pro Asp Asn Thr Glu Phe Ala Gly 165 170 175 Ser Phe Val Ser Val Pro His Ser His Met His Lys Asn Lys Asp Ile 180 185 190 Ile Thr Cys Leu Arg Leu Gly Leu Thr Asp Leu Leu Glu Glu Leu Glu 195 200 205 Ala Glu Asp Asp Asp Ser Val Arg Val Thr Leu Val Pro Arg Tyr Gly 210 215 220 Lys Gly Arg Val Lys Ile Lys Arg His Gln Asn Arg Ala Ser Phe Gly 225 230 235 240 Leu Lys Ile Ile Tyr Met Leu Gln Leu Leu Ile Tyr Val Cys Val Val 245 250 255 Ile His Ile Trp Leu Leu Xaa Phe Gln 260 265 23 510 DNA Glycine max unsure (478) n = a, c, g or t 23 gtcctttttc cttcgtgtcc gtagtcaata atgcctcttc caactcctcc accactcccc 60 cttcttcctt gcatccaatt tcacaattcc aatccactaa aaatagaaag ccaaaacgcc 120 atcacattcc tagaaccaca tgcagtgaaa accaaaacaa tccaacacca aacccatccg 180 aaggagaact atcacatatt gtaggacata ggaggaatgt tctacttggc ctaggagggc 240 tttgtggtgc agttactctt aacaacaacc cttttgcctt tgcagctcca atatctcctc 300 cagacctaaa cacacatgtg gtccaccaga cacacccgcg ggtgcaaatc ccaccaattt 360 gttgcccccc atcttccaaa aatcatagat ttcaaaggtt ccctccttct aaaccaaccc 420 cttgagggta agaccaagcg ggcacatttg ggtcaaaccg atgaaataat ctaagccnaa 480 aatacaaaaa aaggcccttt gacctcaatg 510 24 138 PRT Glycine max 24 Pro Phe Ser Phe Val Ser Val Val Asn Asn Ala Ser Ser Asn Ser Ser 1 5 10 15 Thr Thr Pro Pro Ser Ser Leu His Pro Ile Ser Gln Phe Gln Ser Thr 20 25 30 Lys Asn Arg Lys Pro Lys Arg His His Ile Pro Arg Thr Thr Cys Ser 35 40 45 Glu Asn Gln Asn Asn Pro Thr Pro Asn Pro Ser Glu Gly Glu Leu Ser 50 55 60 His Ile Val Gly His Arg Arg Asn Val Leu Leu Gly Leu Gly Gly Leu 65 70 75 80 Cys Gly Ala Val Thr Leu Asn Asn Asn Pro Phe Ala Phe Ala Ala Pro 85 90 95 Ile Ser Pro Pro Asp Leu Asn Thr His Val Val His Gln Thr His Pro 100 105 110 Arg Val Gln Ile Pro Pro Ile Cys Cys Pro Pro Ser Ser Lys Asn His 115 120 125 Arg Phe Gln Arg Phe Pro Pro Ser Lys Pro 130 135 25 988 DNA Glycine max unsure (962) n = a, c, g or t 25 ctctcctata tccttcgtga gtgcaatcaa taatgtctct tccaactcat ccaattcccc 60 ttcttccttg catcatccct tttcacaaat tcaatccgct aaatatcgaa aaccaaaacg 120 ccatcatcat attcctagag tgacatgcag tgacaaccaa aaaccaaaca catctggaga 180 actagtactc ccacatagga ggaacattct acttggccta ggagggcttt gtggtgctgc 240 tgctactctt aacaacatcc cttttgccaa tgctgcccca atacttggtc cagacctaac 300 cacatgtgtt caagcagaac tacccgaagg tgtagaaccc accaattgtt gtcccccaat 360 ttccacaaac atcatagatt tcaagttccc tccctccaac caacccttgc gtgtacgatc 420 cgctgctcat ctggtcaaca aagactatct agctaaatac gagaaagccg ttaacctgat 480 gaaaaatctc ccgtcagatg atccacgtag tttcgcgcaa caagccaaag ttcattgtgc 540 ttattgcgac ggtggatatc accaactagg cttccctgac cttgatctcg aagtgcactt 600 ctcttggctc ttctttcctt accacagatg gtatctctat ttccatgaaa ggatattggc 660 gagcttgatc aatgatccaa cctttgctct tccattttgg aactgggatg ctcctggggg 720 catgcaactt ccttccatgt acgcagatcc caaatcaccc ctttatgatt ctctacgcaa 780 tgccaaccat caaccaccaa cacttgtaaa ccttgacttt actatcgagg atcctaatgc 840 agaggcaaat atctccacca acctcaccac aatgtatagg caagcttgtg tctaacgcaa 900 agactccaac attgttcttc ggaaatcctt atcgtgctgg ggatcagcta accctggtgg 960 gnggtccgtn nagagcactc cacatggg 988 26 274 PRT Glycine max 26 Ser Pro Ile Ser Phe Val Ser Ala Ile Asn Asn Val Ser Ser Asn Ser 1 5 10 15 Ser Asn Ser Pro Ser Ser Leu His His Pro Phe Ser Gln Ile Gln Ser 20 25 30 Ala Lys Tyr Arg Lys Pro Lys Arg His His His Ile Pro Arg Val Thr 35 40 45 Cys Ser Asp Asn Gln Lys Pro Asn Thr Ser Gly Glu Leu Val Leu Pro 50 55 60 His Arg Arg Asn Ile Leu Leu Gly Leu Gly Gly Leu Cys Gly Ala Ala 65 70 75 80 Ala Thr Leu Asn Asn Ile Pro Phe Ala Asn Ala Ala Pro Ile Leu Gly 85 90 95 Pro Asp Leu Thr Thr Cys Val Gln Ala Glu Leu Pro Glu Gly Val Glu 100 105 110 Pro Thr Asn Cys Cys Pro Pro Ile Ser Thr Asn Ile Ile Asp Phe Lys 115 120 125 Phe Pro Pro Ser Asn Gln Pro Leu Arg Val Arg Ser Ala Ala His Leu 130 135 140 Val Asn Lys Asp Tyr Leu Ala Lys Tyr Glu Lys Ala Val Asn Leu Met 145 150 155 160 Lys Asn Leu Pro Ser Asp Asp Pro Arg Ser Phe Ala Gln Gln Ala Lys 165 170 175 Val His Cys Ala Tyr Cys Asp Gly Gly Tyr His Gln Leu Gly Phe Pro 180 185 190 Asp Leu Asp Leu Glu Val His Phe Ser Trp Leu Phe Phe Pro Tyr His 195 200 205 Arg Trp Tyr Leu Tyr Phe His Glu Arg Ile Leu Ala Ser Leu Ile Asn 210 215 220 Asp Pro Thr Phe Ala Leu Pro Phe Trp Asn Trp Asp Ala Pro Gly Gly 225 230 235 240 Met Gln Leu Pro Ser Met Tyr Ala Asp Pro Lys Ser Pro Leu Tyr Asp 245 250 255 Ser Leu Arg Asn Ala Asn His Gln Pro Pro Thr Leu Val Asn Leu Asp 260 265 270 Phe Thr 27 2044 DNA Glycine max 27 gcacgagctc tcctatatcc ttcgtgagtg caatcaataa tgtctcttcc aactcatcca 60 attccccttc ttccttgcat catccctttt cacaaattca atccgctaaa tatcgaaaac 120 caaaacgcca tcatcatatt cctagagtga catgcagtga caaccaaaaa ccaaacacat 180 ctggagaact agtactccca cataggagga acattctact tggcctagga gggctttgtg 240 gtgctgctgc tactcttaac aacatccctt ttgccaatgc tgccccaata cttggtccag 300 acctaaccac atgtgttcaa gcagaactac ccgaaggtgt agaacccacc aattgttgtc 360 ccccaatttc cacaaacatc atagatttca agttccctcc ctccaaccaa cccttgcgtg 420 tacgatccgc tgctcatctg gtcaacaaag actatctagc taaatacgag aaagccgtta 480 acctgatgaa aaatctcccg tcagatgatc cacgtagttt cgcgcaacaa gccaaagttc 540 attgtgctta ttgcgacggt ggatatcacc aactaggctt ccctgacctt gatctcgaag 600 tgcacttctc ttggctcttc tttccttacc acagatggta tctctatttc catgaaagga 660 tattggcgag cttgatcaat gatccaacct ttgctcttcc attttggaac tgggatgctc 720 ctgggggcat gcaacttcct tccatgtacg cagatcccaa atcacccctt tatgattctc 780 tacgcaatgc caaccatcaa ccaccaacac ttgtaaacct tgactttact atcgaggatc 840 ctaatgcaga ggcaaatatc tccaccaacc tcaccacaat gtataggcag cttgtgtcta 900 acgcaaagac tccaacattg ttcttcggaa atccttatcg tgctggggat cagcctaacc 960 ctggtggtgg ctccgtagag agcactccac atggtcctgt tcatgcatgg accggtgata 1020 tcaaccaccc tacaatggag gacatgggga atttatatgc agctgcaaga gaccccattt 1080 tctattgcca ccattccaat gttgatagga tgtggtccat atggaaaaca cttggtggga 1140 aaagaaggga tttaacagac ccggattggt tagaatccgc gtttctcttc tacgatgaga 1200 ataagaacct tgtgcgtgtg aagactaagg attgtcttga cacgagaaag ttagggtatg 1260 tttaccaaga tgttgacatt ccatggttaa aatctaagcc tacgccatta aggtcaaggg 1320 ctcaaaaggt agaactgaca ccactttttg gtggtgttgc tgcagcacat gctgctgaga 1380 cttcaaggaa tgtgaagttc ccattggtgt tggattcagt tgtgagtaca gtggtgaaga 1440 ggccaaagaa gtctaggagc aaaaaggaga aggaagagaa ggaggagatt ctggtggttg 1500 aagggattga gtttgagagc agcacaggtg tgaagtttga tgtgtttatt aatgatgaag 1560 atgataagtt ggtcaagcca gataatacgg agtttgcagg aagctttgtg agtgtgcctc 1620 attcgcatga gcatcacaaa aacaacaaga agattgttac ttgtttgagg ttgggactaa 1680 cggatttgtt ggaagaattg ggagcagaag atgatgatag tgttctagta acattggttc 1740 ccaagtatgg gaaagggcga gttaacatca gaggcatcaa gatagatttt gtttcagatt 1800 gaaattaaat tgtttatata cttcaaatgt gtgtttgtgc tgtaggtagt aatgcacgca 1860 tggttccttg aagaatttca aatgacgcag gtcactcaga cggagatata tatagtgtat 1920 ttcctataat ataagtttga gacatgtatt agaataatat agcatatcct tattatccta 1980 tgttcactta ctgtgaaata aaataatatt gttgtgatat aaaaaaaaaa aaaaaaaaaa 2040 aaaa 2044 28 599 PRT Glycine max 28 Thr Ser Ser Pro Ile Ser Phe Val Ser Ala Ile Asn Asn Val Ser Ser 1 5 10 15 Asn Ser Ser Asn Ser Pro Ser Ser Leu His His Pro Phe Ser Gln Ile 20 25 30 Gln Ser Ala Lys Tyr Arg Lys Pro Lys Arg His His His Ile Pro Arg 35 40 45 Val Thr Cys Ser Asp Asn Gln Lys Pro Asn Thr Ser Gly Glu Leu Val 50 55 60 Leu Pro His Arg Arg Asn Ile Leu Leu Gly Leu Gly Gly Leu Cys Gly 65 70 75 80 Ala Ala Ala Thr Leu Asn Asn Ile Pro Phe Ala Asn Ala Ala Pro Ile 85 90 95 Leu Gly Pro Asp Leu Thr Thr Cys Val Gln Ala Glu Leu Pro Glu Gly 100 105 110 Val Glu Pro Thr Asn Cys Cys Pro Pro Ile Ser Thr Asn Ile Ile Asp 115 120 125 Phe Lys Phe Pro Pro Ser Asn Gln Pro Leu Arg Val Arg Ser Ala Ala 130 135 140 His Leu Val Asn Lys Asp Tyr Leu Ala Lys Tyr Glu Lys Ala Val Asn 145 150 155 160 Leu Met Lys Asn Leu Pro Ser Asp Asp Pro Arg Ser Phe Ala Gln Gln 165 170 175 Ala Lys Val His Cys Ala Tyr Cys Asp Gly Gly Tyr His Gln Leu Gly 180 185 190 Phe Pro Asp Leu Asp Leu Glu Val His Phe Ser Trp Leu Phe Phe Pro 195 200 205 Tyr His Arg Trp Tyr Leu Tyr Phe His Glu Arg Ile Leu Ala Ser Leu 210 215 220 Ile Asn Asp Pro Thr Phe Ala Leu Pro Phe Trp Asn Trp Asp Ala Pro 225 230 235 240 Gly Gly Met Gln Leu Pro Ser Met Tyr Ala Asp Pro Lys Ser Pro Leu 245 250 255 Tyr Asp Ser Leu Arg Asn Ala Asn His Gln Pro Pro Thr Leu Val Asn 260 265 270 Leu Asp Phe Thr Ile Glu Asp Pro Asn Ala Glu Ala Asn Ile Ser Thr 275 280 285 Asn Leu Thr Thr Met Tyr Arg Gln Leu Val Ser Asn Ala Lys Thr Pro 290 295 300 Thr Leu Phe Phe Gly Asn Pro Tyr Arg Ala Gly Asp Gln Pro Asn Pro 305 310 315 320 Gly Gly Gly Ser Val Glu Ser Thr Pro His Gly Pro Val His Ala Trp 325 330 335 Thr Gly Asp Ile Asn His Pro Thr Met Glu Asp Met Gly Asn Leu Tyr 340 345 350 Ala Ala Ala Arg Asp Pro Ile Phe Tyr Cys His His Ser Asn Val Asp 355 360 365 Arg Met Trp Ser Ile Trp Lys Thr Leu Gly Gly Lys Arg Arg Asp Leu 370 375 380 Thr Asp Pro Asp Trp Leu Glu Ser Ala Phe Leu Phe Tyr Asp Glu Asn 385 390 395 400 Lys Asn Leu Val Arg Val Lys Thr Lys Asp Cys Leu Asp Thr Arg Lys 405 410 415 Leu Gly Tyr Val Tyr Gln Asp Val Asp Ile Pro Trp Leu Lys Ser Lys 420 425 430 Pro Thr Pro Leu Arg Ser Arg Ala Gln Lys Val Glu Leu Thr Pro Leu 435 440 445 Phe Gly Gly Val Ala Ala Ala His Ala Ala Glu Thr Ser Arg Asn Val 450 455 460 Lys Phe Pro Leu Val Leu Asp Ser Val Val Ser Thr Val Val Lys Arg 465 470 475 480 Pro Lys Lys Ser Arg Ser Lys Lys Glu Lys Glu Glu Lys Glu Glu Ile 485 490 495 Leu Val Val Glu Gly Ile Glu Phe Glu Ser Ser Thr Gly Val Lys Phe 500 505 510 Asp Val Phe Ile Asn Asp Glu Asp Asp Lys Leu Val Lys Pro Asp Asn 515 520 525 Thr Glu Phe Ala Gly Ser Phe Val Ser Val Pro His Ser His Glu His 530 535 540 His Lys Asn Asn Lys Lys Ile Val Thr Cys Leu Arg Leu Gly Leu Thr 545 550 555 560 Asp Leu Leu Glu Glu Leu Gly Ala Glu Asp Asp Asp Ser Val Leu Val 565 570 575 Thr Leu Val Pro Lys Tyr Gly Lys Gly Arg Val Asn Ile Arg Gly Ile 580 585 590 Lys Ile Asp Phe Val Ser Asp 595 29 685 DNA Glycine max unsure (478) n = a, c, g or t 29 aaagaagatc gatcatggct tctatatcct gtctatcctc tttctccctc tccaatttct 60 ctgcacctct tcccatttcc atttgttctt catcttccac cttcctaact tcccaaatac 120 catgcaaacc caccaaacgt agcaaaccaa aacgccacca cgtttcgaaa gtgacatgca 180 acagtaacca aaacacccca acaccaaacc cagaagaaga aagaccatca tacaacattc 240 taggaaaata tagaagggat gttctccttg gcattggggg cctttacggt gcatctgctc 300 ttagcaacac caacccttta gccatggctg cagctcctat tctagagcct gacctagaac 360 attgttgtat aactgatgat gtaccaccta aaggggtcat cgaggcacaa gtctattgtt 420 gcccaccaag atcttcttcc cctcctatag atttcaagtt gcctaaagga acaccctnan 480 ggttagacca cctgctcaat tcgtcactga tggagtacct agaaaagtag aagttagccc 540 ttaagcgcat ggganagttc catctgatgn tctcgagttc aggaacangn tggtatcaat 600 gggcttntgt ganggggnnt aaacaatagg gtcccaacng agcnaggtta aggtcacttt 660 ctggcggtct ccctncacgt tggac 685 30 179 PRT Glycine max UNSURE (155)..(156) Xaa = any amino acid 30 Met Ala Ser Ile Ser Cys Leu Ser Ser Phe Ser Leu Ser Asn Phe Ser 1 5 10 15 Ala Pro Leu Pro Ile Ser Ile Cys Ser Ser Ser Ser Thr Phe Leu Thr 20 25 30 Ser Gln Ile Pro Cys Lys Pro Thr Lys Arg Ser Lys Pro Lys Arg His 35 40 45 His Val Ser Lys Val Thr Cys Asn Ser Asn Gln Asn Thr Pro Thr Pro 50 55 60 Asn Pro Glu Glu Glu Arg Pro Ser Tyr Asn Ile Leu Gly Lys Tyr Arg 65 70 75 80 Arg Asp Val Leu Leu Gly Ile Gly Gly Leu Tyr Gly Ala Ser Ala Leu 85 90 95 Ser Asn Thr Asn Pro Leu Ala Met Ala Ala Ala Pro Ile Leu Glu Pro 100 105 110 Asp Leu Glu His Cys Cys Ile Thr Asp Asp Val Pro Pro Lys Gly Val 115 120 125 Ile Glu Ala Gln Val Tyr Cys Cys Pro Pro Arg Ser Ser Ser Pro Pro 130 135 140 Ile Asp Phe Lys Leu Pro Lys Gly Thr Pro Xaa Xaa Leu Asp His Leu 145 150 155 160 Leu Asn Ser Ser Leu Met Glu Tyr Leu Glu Lys Xaa Lys Leu Ala Leu 165 170 175 Lys Arg Met 31 1994 DNA Glycine max 31 gcacgagaaa gaagaacgat catggcttat atctcctctc tatcatcttt ctccctctcc 60 aatttctctg cacctcttcc catttccatt tgttcctcat cttccgcatt cctaacttcc 120 caaataccat gcaaaccctc caaacgtagc aaaccaaaag gccatcatgt ttccaaagtg 180 tcatgcaaca gtaaccaaaa caccccaaca ccaaacccag aagaagaaaa accatcgtca 240 tacaacattc taggaaaaca taggagggat attctccttg gcattggggg cctttacggt 300 gcttctgctc ttagcaacac caacccttta gccatggctg cagctcctat tctagagcct 360 gacctagaac attgttgtat aactgatgat gtacctaaag gggaaatcga gaaacaagtc 420 tattgttgcc caccaaaatc ttcttcccct cctatagatt tcaagttgcc taaaggaaca 480 ccccttaggg ttagaccacc tgctcaattt gtgaccgatg agtacctaga aaagtataag 540 ttagccctta agcgcatgag agagcttcca tctgatgatc ctcgaagttt caagcaacaa 600 gctgatatcc attgtgctta ttgtgatggt ggctataagc aattagggtt cccagttgag 660 ctagacttca aagtccactt ttcatggata tttttccctt tccaccgttg gtacctctat 720 ttctatgagc gaatcttggg tagcttgatt gatgacccaa cctttgcact tccatattgg 780 aactgggaca atcctgatgg tggcatggta ttgccttcca ttttcgcaga tgaagactcc 840 cctctatatg accctcgcag gaatccagac atcacaccaa ctactctcgt agacctaaac 900 tatggcagtg gaaaggaacc aagcgtagaa caaaacctcg gtgtaatgta tacgagtgtt 960 gtctctggtg cgaaacgcgc atcgctcttc catggaaaac catttcttgc tggaaagcag 1020 cctgagctaa gtggagggac cgtagagctt ggtcctcata ctgctgtcca ccgttggacc 1080 ggtgatccaa gacaacctaa caaagaggac atggggaggt tctattctgc tggaagagac 1140 cccgctttct attctcacca tgccaacgtg gatcgtatgt ggaatatatg gaaaacaata 1200 ccaagtggaa aaagaaggga tttcaaaaac cgtgattggt tggaaacctc ctttttcttc 1260 tacgatgaga acaagaccct tgtccgtgtg aaggtgaaag acagccttga cacgaataag 1320 atgggttatg tttaccaaga tgtcgccatt ccatggctcg agaaaaagcc taaacccaaa 1380 agaactagaa aggctaagaa ggtggcgttc gcacaacaat ttggcggcat tggtgcagca 1440 atggctgctg agactgggcc aagttccaag tttcctctca ctttgttgga ctcaaaggta 1500 accctactag ttaaaaggcc aaagcagttg aggagcaaga gggacaagga ggaagaggaa 1560 gaagtgttgg tgattgatgg gattgagttt gatggggatg atgatgtgaa gtttgatgtc 1620 tatattactg atgaagatgt cgaggatatt ggaccagaga gcacagagtt tgcaggaagc 1680 ttttcgactc tgggtcattc ccattcgaac atgaacatgg acaagaagat caaaactagc 1740 ttgacactgg gaataacaga tttgttagag gacttggatg ctgaaaatga tgatagtgtt 1800 ttggtcacat tggtaccacg atctgagaat gtaaccatca caatccagaa cataaagata 1860 gagtttgaga aggatgagtg aaaatatgtc actcatttac tactaaacat gcaaatgagt 1920 ttccaacatg caaatgagtt taaatttata tcagcatgtt tagcaatttc aaagcaaaaa 1980 aaaaaaaaaa aaaa 1994 32 619 PRT Glycine max 32 Met Ala Tyr Ile Ser Ser Leu Ser Ser Phe Ser Leu Ser Asn Phe Ser 1 5 10 15 Ala Pro Leu Pro Ile Ser Ile Cys Ser Ser Ser Ser Ala Phe Leu Thr 20 25 30 Ser Gln Ile Pro Cys Lys Pro Ser Lys Arg Ser Lys Pro Lys Gly His 35 40 45 His Val Ser Lys Val Ser Cys Asn Ser Asn Gln Asn Thr Pro Thr Pro 50 55 60 Asn Pro Glu Glu Glu Lys Pro Ser Ser Tyr Asn Ile Leu Gly Lys His 65 70 75 80 Arg Arg Asp Ile Leu Leu Gly Ile Gly Gly Leu Tyr Gly Ala Ser Ala 85 90 95 Leu Ser Asn Thr Asn Pro Leu Ala Met Ala Ala Ala Pro Ile Leu Glu 100 105 110 Pro Asp Leu Glu His Cys Cys Ile Thr Asp Asp Val Pro Lys Gly Glu 115 120 125 Ile Glu Lys Gln Val Tyr Cys Cys Pro Pro Lys Ser Ser Ser Pro Pro 130 135 140 Ile Asp Phe Lys Leu Pro Lys Gly Thr Pro Leu Arg Val Arg Pro Pro 145 150 155 160 Ala Gln Phe Val Thr Asp Glu Tyr Leu Glu Lys Tyr Lys Leu Ala Leu 165 170 175 Lys Arg Met Arg Glu Leu Pro Ser Asp Asp Pro Arg Ser Phe Lys Gln 180 185 190 Gln Ala Asp Ile His Cys Ala Tyr Cys Asp Gly Gly Tyr Lys Gln Leu 195 200 205 Gly Phe Pro Val Glu Leu Asp Phe Lys Val His Phe Ser Trp Ile Phe 210 215 220 Phe Pro Phe His Arg Trp Tyr Leu Tyr Phe Tyr Glu Arg Ile Leu Gly 225 230 235 240 Ser Leu Ile Asp Asp Pro Thr Phe Ala Leu Pro Tyr Trp Asn Trp Asp 245 250 255 Asn Pro Asp Gly Gly Met Val Leu Pro Ser Ile Phe Ala Asp Glu Asp 260 265 270 Ser Pro Leu Tyr Asp Pro Arg Arg Asn Pro Asp Ile Thr Pro Thr Thr 275 280 285 Leu Val Asp Leu Asn Tyr Gly Ser Gly Lys Glu Pro Ser Val Glu Gln 290 295 300 Asn Leu Gly Val Met Tyr Thr Ser Val Val Ser Gly Ala Lys Arg Ala 305 310 315 320 Ser Leu Phe His Gly Lys Pro Phe Leu Ala Gly Lys Gln Pro Glu Leu 325 330 335 Ser Gly Gly Thr Val Glu Leu Gly Pro His Thr Ala Val His Arg Trp 340 345 350 Thr Gly Asp Pro Arg Gln Pro Asn Lys Glu Asp Met Gly Arg Phe Tyr 355 360 365 Ser Ala Gly Arg Asp Pro Ala Phe Tyr Ser His His Ala Asn Val Asp 370 375 380 Arg Met Trp Asn Ile Trp Lys Thr Ile Pro Ser Gly Lys Arg Arg Asp 385 390 395 400 Phe Lys Asn Arg Asp Trp Leu Glu Thr Ser Phe Phe Phe Tyr Asp Glu 405 410 415 Asn Lys Thr Leu Val Arg Val Lys Val Lys Asp Ser Leu Asp Thr Asn 420 425 430 Lys Met Gly Tyr Val Tyr Gln Asp Val Ala Ile Pro Trp Leu Glu Lys 435 440 445 Lys Pro Lys Pro Lys Arg Thr Arg Lys Ala Lys Lys Val Ala Phe Ala 450 455 460 Gln Gln Phe Gly Gly Ile Gly Ala Ala Met Ala Ala Glu Thr Gly Pro 465 470 475 480 Ser Ser Lys Phe Pro Leu Thr Leu Leu Asp Ser Lys Val Thr Leu Leu 485 490 495 Val Lys Arg Pro Lys Gln Leu Arg Ser Lys Arg Asp Lys Glu Glu Glu 500 505 510 Glu Glu Val Leu Val Ile Asp Gly Ile Glu Phe Asp Gly Asp Asp Asp 515 520 525 Val Lys Phe Asp Val Tyr Ile Thr Asp Glu Asp Val Glu Asp Ile Gly 530 535 540 Pro Glu Ser Thr Glu Phe Ala Gly Ser Phe Ser Thr Leu Gly His Ser 545 550 555 560 His Ser Asn Met Asn Met Asp Lys Lys Ile Lys Thr Ser Leu Thr Leu 565 570 575 Gly Ile Thr Asp Leu Leu Glu Asp Leu Asp Ala Glu Asn Asp Asp Ser 580 585 590 Val Leu Val Thr Leu Val Pro Arg Ser Glu Asn Val Thr Ile Thr Ile 595 600 605 Gln Asn Ile Lys Ile Glu Phe Glu Lys Asp Glu 610 615 33 2028 DNA Glycine max 33 gcacgagggt ccctcctgaa cctgtctgca tccattccca tttcttcttc cgtatgcatg 60 ttcccaccgt ctaaaaaacc tagcaaagca acaaaacggc gtcatgcttg ggaagtagca 120 tgcaatggta accctagaaa taggagggac attctgatcg gccttggagg actctatggt 180 gctacaacaa gtctcacaag taacaacact ggttctgcat ttggtgcttc attgtcgcct 240 ccagatccaa ctaactgcgt tcaaccggac ccagaaaaag accctttttg cccaccaccc 300 cccttcaaag actacgagct ccctccacac gatgacaaga cattacccct tcgaattaga 360 ccagctgctc atttggtcac tgatgattac atagccaagt acgaggaagc cgtgaggcgc 420 atgcaagacc ttccacctga tgatcctcgc agtttcatgc aacaggccaa tgtccaccgt 480 gcctactgcg atggtcgcgg ctatactcaa aagggcttcg ctgactacaa gcttgacgtt 540 cacggctcct ggatattctt tccttggcac cgctggtatc tctatttcta tgagaaaatc 600 ttggggaaga tgatcggtga ccccactttc gctcttccgt tttggaactg ggacaatccc 660 gccggcatga gaatccctcc cattttcaca gacaaaagtt cgcctctcta cgacgaacac 720 aggaatagcg atcatgtaaa tgctttcatc gacctagact acaagaagga cgattctcct 780 gtgaaacctc ctcaaacaat tttatggccg ccagtggaga aaaagaataa ctcgatcgtc 840 gacaacttga tcgtcaacaa cttgataaaa gtttatacgg cagttgcaag caaaaccaac 900 tcaagcccag actacttcct cgggccagca ttcgaagctg gttctgcacc tcagcaacac 960 tttggatctc tggaatcttt gcacaatact gtccacagct ggaccggtga aagagaaaac 1020 aatcaccacg acatggggtt gttggctacg gctgcaaaag atcccatttt ctttgctcac 1080 cattcaaacg tcgataggat gtggaacata tggaagacag aattgctgga tggaagaaga 1140 tttgatcaca aaagtgacga ctggttggaa tccagtttct tcttctacga cgagaacaag 1200 aactatgtgc gtgtgaaggt caaagactgc ctcgactcca agaagatggg gtatgattac 1260 caacgtgttg accttccatg gctgttggct ggggaactca tcaaaccaaa gaaggagatt 1320 attctccttc gttcaaaacc agaagcttca acattcaaga cattacagct ccctctccct 1380 ctggaatcca ttgagcgtac aaacgtgaag aggccgaagc cgcgatccag gaacgagaat 1440 gaagaagaag aagaaggcgt agaagaggtg ttagtgatag atgttgagta cgatagcact 1500 gatggtgtga ggtttgatgt gttcatcaac gaccaaggcg acaatgagat tggaccccag 1560 gattcagagt ttgcgggaag ctttgtgact ttgcctcact cgccgcatgt caaccataac 1620 aacatcacca aagcttcttt caaattgcca ttaacgtata agttgaaaga cttgggagta 1680 acaaaagacg atgatagtat ttctgtcaca ctggctccca tatatgggga caagcctgtt 1740 acaattaagg acgtaaggat aaagcgtgtt tatcctgagg tggacgatga ataaatctaa 1800 attatgtgtg tgctactgct agggtttgtt cctccaaggg atactctatc tgtcatttgt 1860 tgtttcttaa ttagtgtgtt gtagttattt tccttggaac ttaatagatc cctttcatct 1920 gtgagggata ctatgttatt gttataataa atgtttgttt tattgttaca tttgtttata 1980 atacaatata actcctaatc tccttttaaa aaaaaaaaaa aaaaaaaa 2028 34 597 PRT Glycine max 34 Ala Arg Gly Ser Leu Leu Asn Leu Ser Ala Ser Ile Pro Ile Ser Ser 1 5 10 15 Ser Val Cys Met Phe Pro Pro Ser Lys Lys Pro Ser Lys Ala Thr Lys 20 25 30 Arg Arg His Ala Trp Glu Val Ala Cys Asn Gly Asn Pro Arg Asn Arg 35 40 45 Arg Asp Ile Leu Ile Gly Leu Gly Gly Leu Tyr Gly Ala Thr Thr Ser 50 55 60 Leu Thr Ser Asn Asn Thr Gly Ser Ala Phe Gly Ala Ser Leu Ser Pro 65 70 75 80 Pro Asp Pro Thr Asn Cys Val Gln Pro Asp Pro Glu Lys Asp Pro Phe 85 90 95 Cys Pro Pro Pro Pro Phe Lys Asp Tyr Glu Leu Pro Pro His Asp Asp 100 105 110 Lys Thr Leu Pro Leu Arg Ile Arg Pro Ala Ala His Leu Val Thr Asp 115 120 125 Asp Tyr Ile Ala Lys Tyr Glu Glu Ala Val Arg Arg Met Gln Asp Leu 130 135 140 Pro Pro Asp Asp Pro Arg Ser Phe Met Gln Gln Ala Asn Val His Arg 145 150 155 160 Ala Tyr Cys Asp Gly Arg Gly Tyr Thr Gln Lys Gly Phe Ala Asp Tyr 165 170 175 Lys Leu Asp Val His Gly Ser Trp Ile Phe Phe Pro Trp His Arg Trp 180 185 190 Tyr Leu Tyr Phe Tyr Glu Lys Ile Leu Gly Lys Met Ile Gly Asp Pro 195 200 205 Thr Phe Ala Leu Pro Phe Trp Asn Trp Asp Asn Pro Ala Gly Met Arg 210 215 220 Ile Pro Pro Ile Phe Thr Asp Lys Ser Ser Pro Leu Tyr Asp Glu His 225 230 235 240 Arg Asn Ser Asp His Val Asn Ala Phe Ile Asp Leu Asp Tyr Lys Lys 245 250 255 Asp Asp Ser Pro Val Lys Pro Pro Gln Thr Ile Leu Trp Pro Pro Val 260 265 270 Glu Lys Lys Asn Asn Ser Ile Val Asp Asn Leu Ile Val Asn Asn Leu 275 280 285 Ile Lys Val Tyr Thr Ala Val Ala Ser Lys Thr Asn Ser Ser Pro Asp 290 295 300 Tyr Phe Leu Gly Pro Ala Phe Glu Ala Gly Ser Ala Pro Gln Gln His 305 310 315 320 Phe Gly Ser Leu Glu Ser Leu His Asn Thr Val His Ser Trp Thr Gly 325 330 335 Glu Arg Glu Asn Asn His His Asp Met Gly Leu Leu Ala Thr Ala Ala 340 345 350 Lys Asp Pro Ile Phe Phe Ala His His Ser Asn Val Asp Arg Met Trp 355 360 365 Asn Ile Trp Lys Thr Glu Leu Leu Asp Gly Arg Arg Phe Asp His Lys 370 375 380 Ser Asp Asp Trp Leu Glu Ser Ser Phe Phe Phe Tyr Asp Glu Asn Lys 385 390 395 400 Asn Tyr Val Arg Val Lys Val Lys Asp Cys Leu Asp Ser Lys Lys Met 405 410 415 Gly Tyr Asp Tyr Gln Arg Val Asp Leu Pro Trp Leu Leu Ala Gly Glu 420 425 430 Leu Ile Lys Pro Lys Lys Glu Ile Ile Leu Leu Arg Ser Lys Pro Glu 435 440 445 Ala Ser Thr Phe Lys Thr Leu Gln Leu Pro Leu Pro Leu Glu Ser Ile 450 455 460 Glu Arg Thr Asn Val Lys Arg Pro Lys Pro Arg Ser Arg Asn Glu Asn 465 470 475 480 Glu Glu Glu Glu Glu Gly Val Glu Glu Val Leu Val Ile Asp Val Glu 485 490 495 Tyr Asp Ser Thr Asp Gly Val Arg Phe Asp Val Phe Ile Asn Asp Gln 500 505 510 Gly Asp Asn Glu Ile Gly Pro Gln Asp Ser Glu Phe Ala Gly Ser Phe 515 520 525 Val Thr Leu Pro His Ser Pro His Val Asn His Asn Asn Ile Thr Lys 530 535 540 Ala Ser Phe Lys Leu Pro Leu Thr Tyr Lys Leu Lys Asp Leu Gly Val 545 550 555 560 Thr Lys Asp Asp Asp Ser Ile Ser Val Thr Leu Ala Pro Ile Tyr Gly 565 570 575 Asp Lys Pro Val Thr Ile Lys Asp Val Arg Ile Lys Arg Val Tyr Pro 580 585 590 Glu Val Asp Asp Glu 595 35 2260 DNA Glycine max 35 ccttgaggag tatcactagt tcggcagcgg cgccaccgcg gtgaacaccc cgggctgcag 60 gaattcggca cgagaatgag tactccttct aagcttttat ctttattctt tgtactcatt 120 gtcttgctga tgcccttagt ttccttactc aacaatgatt tctctatctt caccattaaa 180 accatttcat acctagtttc ctttagtgaa aagccaaacc attactctaa tttcagcatt 240 attccataca aagcccaaaa tagtaaacaa aatggccaca tcaccacaaa ctccaatgga 300 agagacaaac cacgtctttg gaggaaagcc ttcattggct tcaaaaatac tcacgagcca 360 tcttcgaata tttctcgagc aatatccctt aatgtaagca agtgttttcc cgttgagtta 420 ccttcttttg caataaccaa ttcccattgt tgtccaccta gaccacctcc ttctaagatc 480 atagatttca aagattttgc ttctccaaac gccacgcttc gagtaagaaa accggctcac 540 atggtagatg aggagtacat agcaaaactt gaaaagggca ttgcactcat gaaagcactc 600 cctgatgatg acccacgtaa tttcatacaa caagcaaagg tccattgtgc ttattgtaac 660 ggtgcctatc acctacccca tccctttcag aacacaaaac tcaacattca caggtcttgg 720 tttttctttc ctttccaccg ttggtacatt tacttcttcg agcgaatctt gggaagcttg 780 ctcggtgacc cgaactttgc cttaccgttt tggaattggg atgctgtaga agggatgcaa 840 atgccaccat atttcgcaaa ccctaactcg tcgctctatc acaaactccg aaaccccaag 900 cacttgccac cgcaagtggt tgacctgaac tatgatccat ttgactttaa tgatgataca 960 ccttctcatc aacaagtttc gtataatcta gccttcatgt acaagcaaat ggtgctagca 1020 agtaccaaag aattgttcat gggaagccct tttcgactcg gcgataaccc tactccgggt 1080 attggctcta tagaggctgc tcctcataac acggttcata aatgggttgg tgctgctgat 1140 aagccacacc aggaggacat gggaacgttc tacacagctg ctagagatcc cgttttctat 1200 ccgcatcaca cgaactcgga tcgactgtgg gggatatgga aaaaattggg agaaggaaga 1260 aaggactata gtgatgatcc agattggtta gattctgatt tttacttcta tgatgagaat 1320 gccaattttg ttcgcgtgaa ggtaagagat tgctttgata ctaaaagatt ggggtatgtt 1380 tacgaagatg ttgatcttcc atggttgcga acgccaccca catcgcgaaa aagcaagcta 1440 ctaagagaag ccaaaaaggg ttcacttttg agttcaaagc catggaaatt tcctttggtt 1500 ttggattcca taacgagtat tgttgttaag aggccgaaga aatggaggag caaggaggag 1560 aaagaacaag aggaggaggt tttggtgata gaagggattg agtttggaag tgataaatat 1620 gtcaagtttg atgttcatat tgatgatgat gaagacaatt tgagtggtcc ggatgagaca 1680 gagtttgtgg gaagttttgt gaatgtgcag catgggcatg gccataatgt caaaactagc 1740 tttaaggtag ggatatcgaa agtgctggag agtgtagaag ctgaagaaga cgatgaggtg 1800 ctggtttctt tggtacctaa ggtgggaaaa ggggatgcca taataggagg catcaaaatt 1860 gagtttattc caaaatacta ggattatttt gtgggtgtga aaattttaca ctttttacaa 1920 gttttgttgt ttatgctttt aaaaggtagt tttttttttt tccttttttt agtgtagcaa 1980 gtcgagctcg tattctctgt ggctggattt tgtccaacta actgaaatat gagatgtcga 2040 atttgctata tattttacag caattgggga agggaaagaa tgtgaaggaa gttgaaattt 2100 tggatgtggg gaagtactcc tagaagtaga tataaatttg ttgtggtgca tgtctttcaa 2160 cactagtgca tgtaaagaaa atcaaataaa tcaatttgat tttctagaac taattttcat 2220 aataaaaaat tgagtttgat gtaaaaaaaa aaaaaaaaaa 2260 36 601 PRT Glycine max 36 Met Ser Thr Pro Ser Lys Leu Leu Ser Leu Phe Phe Val Leu Ile Val 1 5 10 15 Leu Leu Met Pro Leu Val Ser Leu Leu Asn Asn Asp Phe Ser Ile Phe 20 25 30 Thr Ile Lys Thr Ile Ser Tyr Leu Val Ser Phe Ser Glu Lys Pro Asn 35 40 45 His Tyr Ser Asn Phe Ser Ile Ile Pro Tyr Lys Ala Gln Asn Ser Lys 50 55 60 Gln Asn Gly His Ile Thr Thr Asn Ser Asn Gly Arg Asp Lys Pro Arg 65 70 75 80 Leu Trp Arg Lys Ala Phe Ile Gly Phe Lys Asn Thr His Glu Pro Ser 85 90 95 Ser Asn Ile Ser Arg Ala Ile Ser Leu Asn Val Ser Lys Cys Phe Pro 100 105 110 Val Glu Leu Pro Ser Phe Ala Ile Thr Asn Ser His Cys Cys Pro Pro 115 120 125 Arg Pro Pro Pro Ser Lys Ile Ile Asp Phe Lys Asp Phe Ala Ser Pro 130 135 140 Asn Ala Thr Leu Arg Val Arg Lys Pro Ala His Met Val Asp Glu Glu 145 150 155 160 Tyr Ile Ala Lys Leu Glu Lys Gly Ile Ala Leu Met Lys Ala Leu Pro 165 170 175 Asp Asp Asp Pro Arg Asn Phe Ile Gln Gln Ala Lys Val His Cys Ala 180 185 190 Tyr Cys Asn Gly Ala Tyr His Leu Pro His Pro Phe Gln Asn Thr Lys 195 200 205 Leu Asn Ile His Arg Ser Trp Phe Phe Phe Pro Phe His Arg Trp Tyr 210 215 220 Ile Tyr Phe Phe Glu Arg Ile Leu Gly Ser Leu Leu Gly Asp Pro Asn 225 230 235 240 Phe Ala Leu Pro Phe Trp Asn Trp Asp Ala Val Glu Gly Met Gln Met 245 250 255 Pro Pro Tyr Phe Ala Asn Pro Asn Ser Ser Leu Tyr His Lys Leu Arg 260 265 270 Asn Pro Lys His Leu Pro Pro Gln Val Val Asp Leu Asn Tyr Asp Pro 275 280 285 Phe Asp Phe Asn Asp Asp Thr Pro Ser His Gln Gln Val Ser Tyr Asn 290 295 300 Leu Ala Phe Met Tyr Lys Gln Met Val Leu Ala Ser Thr Lys Glu Leu 305 310 315 320 Phe Met Gly Ser Pro Phe Arg Leu Gly Asp Asn Pro Thr Pro Gly Ile 325 330 335 Gly Ser Ile Glu Ala Ala Pro His Asn Thr Val His Lys Trp Val Gly 340 345 350 Ala Ala Asp Lys Pro His Gln Glu Asp Met Gly Thr Phe Tyr Thr Ala 355 360 365 Ala Arg Asp Pro Val Phe Tyr Pro His His Thr Asn Ser Asp Arg Leu 370 375 380 Trp Gly Ile Trp Lys Lys Leu Gly Glu Gly Arg Lys Asp Tyr Ser Asp 385 390 395 400 Asp Pro Asp Trp Leu Asp Ser Asp Phe Tyr Phe Tyr Asp Glu Asn Ala 405 410 415 Asn Phe Val Arg Val Lys Val Arg Asp Cys Phe Asp Thr Lys Arg Leu 420 425 430 Gly Tyr Val Tyr Glu Asp Val Asp Leu Pro Trp Leu Arg Thr Pro Pro 435 440 445 Thr Ser Arg Lys Ser Lys Leu Leu Arg Glu Ala Lys Lys Gly Ser Leu 450 455 460 Leu Ser Ser Lys Pro Trp Lys Phe Pro Leu Val Leu Asp Ser Ile Thr 465 470 475 480 Ser Ile Val Val Lys Arg Pro Lys Lys Trp Arg Ser Lys Glu Glu Lys 485 490 495 Glu Gln Glu Glu Glu Val Leu Val Ile Glu Gly Ile Glu Phe Gly Ser 500 505 510 Asp Lys Tyr Val Lys Phe Asp Val His Ile Asp Asp Asp Glu Asp Asn 515 520 525 Leu Ser Gly Pro Asp Glu Thr Glu Phe Val Gly Ser Phe Val Asn Val 530 535 540 Gln His Gly His Gly His Asn Val Lys Thr Ser Phe Lys Val Gly Ile 545 550 555 560 Ser Lys Val Leu Glu Ser Val Glu Ala Glu Glu Asp Asp Glu Val Leu 565 570 575 Val Ser Leu Val Pro Lys Val Gly Lys Gly Asp Ala Ile Ile Gly Gly 580 585 590 Ile Lys Ile Glu Phe Ile Pro Lys Tyr 595 600 37 1141 DNA Zea mays unsure (16) n = a, c, g or t 37 ccgacaaccc gctgtncgac ccctaccgca acatggagaa catggacgcc ctgctcgatn 60 tggactacct caagaaaccc agacgcgaca ccatcccttt cgagccgccg acggacccag 120 ccgcgcgcgc caagtacgac gacgccgttc aaaccaacct gtgcaccata tacctgcagc 180 aagtccgtga cggcaagggc ccccgtgctt tcctcggcga gaagctgtgc agcgaccagg 240 gcacgctgga gcggatggcg cacacgacgg tgcacgtgtg gacggggcgg gcgaacccgg 300 cgacgtgcag cgcggagcag ggcggcgtgg tggggcacga cggcaagccg cactgccagg 360 tggacatggg gttcctgggc acggcggggc gtgacccgct cttctactcg caccacgcga 420 acgtggaccg catgtggcac atctggtcca ctaggctggg cggtaagggc ttcgacgacc 480 cggagtggct ggacaccagc ttcgtgttct acgacgacta ccggagccgc ggctggtgac 540 agatgaagtt ccgcgacgtc ctgaacgcga ccaggctcgg gtacacgtac gacaaggagt 600 cggaggcggc gctgccgtgg ctgaacagca agccgacccg gttctccggc ggcggcaagg 660 cgaaggcgaa ggcggcgccc aaggtggcgt cggagttccc gctgaccctg acggacgagg 720 ccgtggacgt gccggcggtg gcggtcccgg cgcggcaggc cgggaaggac ctggtgctgc 780 tgatcgaggg catcgagtac gacccccaga tcaacaacaa gttcgacgtg gtcatcaacg 840 tggcccggga ggacgccgcg agggtggggc ctaaggacag cgagtacgcc ggcagcttca 900 gcgccgtgcc cagctccaac gccgccggtg gcacgctggt gggcaagttc acgctcgccc 960 tcgacggcgt gctcgccgac ctcgggctcg ccggcgcgag cgccgtcgac atcgtgctcg 1020 tccctcacac ggagggcgag atcaagctgt acttgccccc gaccatcgag aacgcgtgag 1080 aactgagatg agatgagacc cgccacgcac tggctggctg gctgttcgtc tgtccaccgt 1140 c 1141 38 358 PRT Zea mays UNSURE (5) Xaa = any amino acid 38 Asp Asn Pro Leu Xaa Asp Pro Tyr Arg Asn Met Glu Asn Met Asp Ala 1 5 10 15 Leu Leu Asp Xaa Asp Tyr Leu Lys Lys Pro Arg Arg Asp Thr Ile Pro 20 25 30 Phe Glu Pro Pro Thr Asp Pro Ala Ala Arg Ala Lys Tyr Asp Asp Ala 35 40 45 Val Gln Thr Asn Leu Cys Thr Ile Tyr Leu Gln Gln Val Arg Asp Gly 50 55 60 Lys Gly Pro Arg Ala Phe Leu Gly Glu Lys Leu Cys Ser Asp Gln Gly 65 70 75 80 Thr Leu Glu Arg Met Ala His Thr Thr Val His Val Trp Thr Gly Arg 85 90 95 Ala Asn Pro Ala Thr Cys Ser Ala Glu Gln Gly Gly Val Val Gly His 100 105 110 Asp Gly Lys Pro His Cys Gln Val Asp Met Gly Phe Leu Gly Thr Ala 115 120 125 Gly Arg Asp Pro Leu Phe Tyr Ser His His Ala Asn Val Asp Arg Met 130 135 140 Trp His Ile Trp Ser Thr Arg Leu Gly Gly Lys Gly Phe Asp Asp Pro 145 150 155 160 Glu Trp Leu Asp Thr Ser Phe Val Phe Tyr Asp Asp Tyr Arg Ser Arg 165 170 175 Gly Trp Xaa Gln Met Lys Phe Arg Asp Val Leu Asn Ala Thr Arg Leu 180 185 190 Gly Tyr Thr Tyr Asp Lys Glu Ser Glu Ala Ala Leu Pro Trp Leu Asn 195 200 205 Ser Lys Pro Thr Arg Phe Ser Gly Gly Gly Lys Ala Lys Ala Lys Ala 210 215 220 Ala Pro Lys Val Ala Ser Glu Phe Pro Leu Thr Leu Thr Asp Glu Ala 225 230 235 240 Val Asp Val Pro Ala Val Ala Val Pro Ala Arg Gln Ala Gly Lys Asp 245 250 255 Leu Val Leu Leu Ile Glu Gly Ile Glu Tyr Asp Pro Gln Ile Asn Asn 260 265 270 Lys Phe Asp Val Val Ile Asn Val Ala Arg Glu Asp Ala Ala Arg Val 275 280 285 Gly Pro Lys Asp Ser Glu Tyr Ala Gly Ser Phe Ser Ala Val Pro Ser 290 295 300 Ser Asn Ala Ala Gly Gly Thr Leu Val Gly Lys Phe Thr Leu Ala Leu 305 310 315 320 Asp Gly Val Leu Ala Asp Leu Gly Leu Ala Gly Ala Ser Ala Val Asp 325 330 335 Ile Val Leu Val Pro His Thr Glu Gly Glu Ile Lys Leu Tyr Leu Pro 340 345 350 Pro Thr Ile Glu Asn Ala 355 39 2173 DNA Zea mays 39 gcgtggcaac gtccaaaatc cagaccgctg gtaggagtat ctcgtagaca ttgaacaacg 60 gctgcatggc gagcgcctgc gccacctcca tccccctcgt ctcggcgccc tctgcatgcc 120 cgtccaagaa gaccaccgtc gccaggttcc ggcgccgcac ggcgacgtgc agggccagca 180 gcggcggtgg cggtggccgg ggcggcgaaa atgatggcct cctttggctg ccccggcggg 240 acgtgatgct caacggcctg tccagtgtcg ccgccgggct cgcctggtac ccgggcgtcg 300 cgtccggcgc ggatgcggtg tgcaccaggg ccgacaaggt gaacgagaag accgtgcagt 360 gcacggaccc ggccgggcag cttccgtgcc ctctggtgtc gccgacggac cccgtggact 420 tcaagccgga aagcaaggtg acgcgcatcc ggcagccggt gcatctcctg agccgggagt 480 accaggagaa gtacaaggag gccgtcgcga agatgaaggc gctaccggaa gagaacccgc 540 tgagcttcgc ggcccaggcg gccatccacc aggcttactg cgacgcctac tacaagtacg 600 acccgacggc caaggacgcg ccgttcgacg tgcacttctc gtggatcttc gcgccgtggc 660 accgcatgta catctacttc tacgagcgcg ccctcgggca gctcatcggc gacgacacct 720 tcgcgctgcc gttctggaac tgggacacgc cggccggcat ggtggtgccg ccactcttca 780 aggactccat gggcaacccg ctgtacgacc ccaacaggaa cccgtcgaac gtcgacgcgc 840 tggtggactt agactacctc aacgacagga atgcggagcc catccctttc aagggcccac 900 gggacgaaaa gtacaaggaa cttgtgaaca agaacctgtg caccgtatac acccagcaaa 960 tacgtagcgg caagggcgcc gagtcgttcc tgggcgagaa gtactgcacc gacatcgggt 1020 caagcacgag cagcatgggt tcgctggagc ggatggcgca cactgccgtg cacgtctggg 1080 tcggcaaggc gggcccgacg ccttcctcgg aggcgtgcag tgccgctacc ggcggcttcc 1140 cgaaccacac caaaggcggg tacagctgca acaacgacat ggggttcctg gggtcggcgg 1200 gacacgaccc gctcttctac tcgcaccact ccaacgtcga ccgcatgtgg cacatctggt 1260 cgaccaggct cggcggcggg cagggcatca cggaggcgga ctggctcgac accagcttcg 1320 tcttctacga cgacgtcaag agcccgcgga aggtgcgcat caggttccgc gacgtcctgg 1380 acacgcgcga cctcggctac acgtacgacg ccgagtccga caaggacctg ccatggctgc 1440 gctgcaagat ctcgtcgctg gtgccccacg gcaaggacag cccgccgagg tcgtcgtcgg 1500 caaggaaggc ggcgccggtg ttcccgctcg ccctgactaa gggccaggtg gtggaagtgc 1560 cggccgtgcc tgtgccggcc aaggacccgg ggaaggagca gctgctggtg atcgagggca 1620 tcgagtacga cccccaggcg aacaataagt tcgacgtcgc catcaacctg cccgcggaca 1680 aagcgttgca ggtaggccca cagtacaagg agtacgccgg aagcttcgcc gtcgtgccgg 1740 gctccggcgc cgggaagacg cggaaagtga agctctccct gtgcatcacc gaagtgctgt 1800 tcgatatcga cgctgacggc gataaaaccg tcgacgtcgt tatcgtgccg cgcacaaatg 1860 ctaagatcac gctcaacgct cgccccacca tcaagaatcg gaactaggag ctagttgcta 1920 ctagtgctca tcaagcacac tgtacgtacg tacgtatgta ctcgatcgcg tggtcattca 1980 tcgaccatca tcgtttatat gctgtcacgc acagcgcggg ccggccggta gggtgtcggc 2040 aataataaac gcggccagtg ttgcattatt gtgtgtttta tttcacaagg attaggagcg 2100 agccaatggt agattctaag gaataaataa cattgttatg aatgatatgg ttatgtttta 2160 gagactaatt gcg 2173 40 613 PRT Zea mays 40 Met Ala Ser Ala Cys Ala Thr Ser Ile Pro Leu Val Ser Ala Pro Ser 1 5 10 15 Ala Cys Pro Ser Lys Lys Thr Thr Val Ala Arg Phe Arg Arg Arg Thr 20 25 30 Ala Thr Cys Arg Ala Ser Ser Gly Gly Gly Gly Gly Arg Gly Gly Glu 35 40 45 Asn Asp Gly Leu Leu Trp Leu Pro Arg Arg Asp Val Met Leu Asn Gly 50 55 60 Leu Ser Ser Val Ala Ala Gly Leu Ala Trp Tyr Pro Gly Val Ala Ser 65 70 75 80 Gly Ala Asp Ala Val Cys Thr Arg Ala Asp Lys Val Asn Glu Lys Thr 85 90 95 Val Gln Cys Thr Asp Pro Ala Gly Gln Leu Pro Cys Pro Leu Val Ser 100 105 110 Pro Thr Asp Pro Val Asp Phe Lys Pro Glu Ser Lys Val Thr Arg Ile 115 120 125 Arg Gln Pro Val His Leu Leu Ser Arg Glu Tyr Gln Glu Lys Tyr Lys 130 135 140 Glu Ala Val Ala Lys Met Lys Ala Leu Pro Glu Glu Asn Pro Leu Ser 145 150 155 160 Phe Ala Ala Gln Ala Ala Ile His Gln Ala Tyr Cys Asp Ala Tyr Tyr 165 170 175 Lys Tyr Asp Pro Thr Ala Lys Asp Ala Pro Phe Asp Val His Phe Ser 180 185 190 Trp Ile Phe Ala Pro Trp His Arg Met Tyr Ile Tyr Phe Tyr Glu Arg 195 200 205 Ala Leu Gly Gln Leu Ile Gly Asp Asp Thr Phe Ala Leu Pro Phe Trp 210 215 220 Asn Trp Asp Thr Pro Ala Gly Met Val Val Pro Pro Leu Phe Lys Asp 225 230 235 240 Ser Met Gly Asn Pro Leu Tyr Asp Pro Asn Arg Asn Pro Ser Asn Val 245 250 255 Asp Ala Leu Val Asp Leu Asp Tyr Leu Asn Asp Arg Asn Ala Glu Pro 260 265 270 Ile Pro Phe Lys Gly Pro Arg Asp Glu Lys Tyr Lys Glu Leu Val Asn 275 280 285 Lys Asn Leu Cys Thr Val Tyr Thr Gln Gln Ile Arg Ser Gly Lys Gly 290 295 300 Ala Glu Ser Phe Leu Gly Glu Lys Tyr Cys Thr Asp Ile Gly Ser Ser 305 310 315 320 Thr Ser Ser Met Gly Ser Leu Glu Arg Met Ala His Thr Ala Val His 325 330 335 Val Trp Val Gly Lys Ala Gly Pro Thr Pro Ser Ser Glu Ala Cys Ser 340 345 350 Ala Ala Thr Gly Gly Phe Pro Asn His Thr Lys Gly Gly Tyr Ser Cys 355 360 365 Asn Asn Asp Met Gly Phe Leu Gly Ser Ala Gly His Asp Pro Leu Phe 370 375 380 Tyr Ser His His Ser Asn Val Asp Arg Met Trp His Ile Trp Ser Thr 385 390 395 400 Arg Leu Gly Gly Gly Gln Gly Ile Thr Glu Ala Asp Trp Leu Asp Thr 405 410 415 Ser Phe Val Phe Tyr Asp Asp Val Lys Ser Pro Arg Lys Val Arg Ile 420 425 430 Arg Phe Arg Asp Val Leu Asp Thr Arg Asp Leu Gly Tyr Thr Tyr Asp 435 440 445 Ala Glu Ser Asp Lys Asp Leu Pro Trp Leu Arg Cys Lys Ile Ser Ser 450 455 460 Leu Val Pro His Gly Lys Asp Ser Pro Pro Arg Ser Ser Ser Ala Arg 465 470 475 480 Lys Ala Ala Pro Val Phe Pro Leu Ala Leu Thr Lys Gly Gln Val Val 485 490 495 Glu Val Pro Ala Val Pro Val Pro Ala Lys Asp Pro Gly Lys Glu Gln 500 505 510 Leu Leu Val Ile Glu Gly Ile Glu Tyr Asp Pro Gln Ala Asn Asn Lys 515 520 525 Phe Asp Val Ala Ile Asn Leu Pro Ala Asp Lys Ala Leu Gln Val Gly 530 535 540 Pro Gln Tyr Lys Glu Tyr Ala Gly Ser Phe Ala Val Val Pro Gly Ser 545 550 555 560 Gly Ala Gly Lys Thr Arg Lys Val Lys Leu Ser Leu Cys Ile Thr Glu 565 570 575 Val Leu Phe Asp Ile Asp Ala Asp Gly Asp Lys Thr Val Asp Val Val 580 585 590 Ile Val Pro Arg Thr Asn Ala Lys Ile Thr Leu Asn Ala Arg Pro Thr 595 600 605 Ile Lys Asn Arg Asn 610 41 409 DNA Zea mays unsure (409) n = a, c, g or t 41 ccagctgatt tgtccacgcg gcatggcgac ggccagcgcc gcttcaagct tcctcgtccc 60 ggcgactgct atcgccccga caccctctgc atgcccatcc acggttccca agaacaagaa 120 gaatgctgcc ggccggcggc ggcgcacatt gcagtgcagg gccagcggcc ggcggggcga 180 cgacgaagac agccgcctcc tctggctgcc ccggcgggaa gtgctgaccg gtctgggcgg 240 cgtggccgcc agcttcgtcg ggtacccgga tctggcttcc atcgccctgg aagcgaaccc 300 cgtggagagc tgccggcggg gcgagaaggt gacggagaag ctggtggagt gctcggaccc 360 gaacagagac ttcccgtgcc cgccggcgtc acgggtcccc atcgtggan 409 42 123 PRT Zea mays 42 Met Ala Thr Ala Ser Ala Ala Ser Ser Phe Leu Val Pro Ala Thr Ala 1 5 10 15 Ile Ala Pro Thr Pro Ser Ala Cys Pro Ser Thr Val Pro Lys Asn Lys 20 25 30 Lys Asn Ala Ala Gly Arg Arg Arg Arg Thr Leu Gln Cys Arg Ala Ser 35 40 45 Gly Arg Arg Gly Asp Asp Glu Asp Ser Arg Leu Leu Trp Leu Pro Arg 50 55 60 Arg Glu Val Leu Thr Gly Leu Gly Gly Val Ala Ala Ser Phe Val Gly 65 70 75 80 Tyr Pro Asp Leu Ala Ser Ile Ala Leu Glu Ala Asn Pro Val Glu Ser 85 90 95 Cys Arg Arg Gly Glu Lys Val Thr Glu Lys Leu Val Glu Cys Ser Asp 100 105 110 Pro Asn Arg Asp Phe Pro Cys Pro Pro Ala Ser 115 120 43 497 DNA Glycine max unsure (325) n = a, c, g or t 43 gacctagact acaacggcgt tgaagaccaa tcctcaacac aagaacaaat atcaaccaat 60 ctcaacacca tgtaccggca actggtgtca agttcaaaga ctccaacgct cttcttcggt 120 agcccttacc gtgcaggaga agatagtgat cccggtggtg gcactgtgga gaacattcct 180 cacggtccgg tccatatatg gaccggtgat aacacacaac ctaactttga ggacatgggg 240 actctctatt ctgctgctag agaccctatt ttctattctc accacgctaa tgtggataga 300 atgtggtcca tatggaaaac tcttngagga aagagagtga catcaaagac cctgattgtt 360 ggaatctggg ttctttctac gatgagaaca agaatcntgt cgtgtgaggt naggattgtc 420 tngtactaga agcttgantg ntaccaaatg atntgtccgt ggnaaancta gccaaancgg 480 tttcgangng gtcaaga 497 44 112 PRT Glycine max UNSURE (109) Xaa = any amino acid 44 Asp Leu Asp Tyr Asn Gly Val Glu Asp Gln Ser Ser Thr Gln Glu Gln 1 5 10 15 Ile Ser Thr Asn Leu Asn Thr Met Tyr Arg Gln Leu Val Ser Ser Ser 20 25 30 Lys Thr Pro Thr Leu Phe Phe Gly Ser Pro Tyr Arg Ala Gly Glu Asp 35 40 45 Ser Asp Pro Gly Gly Gly Thr Val Glu Asn Ile Pro His Gly Pro Val 50 55 60 His Ile Trp Thr Gly Asp Asn Thr Gln Pro Asn Phe Glu Asp Met Gly 65 70 75 80 Thr Leu Tyr Ser Ala Ala Arg Asp Pro Ile Phe Tyr Ser His His Ala 85 90 95 Asn Val Asp Arg Met Trp Ser Ile Trp Lys Thr Leu Xaa Gly Lys Arg 100 105 110 45 713 DNA Glycine max unsure (579) n = a, c, g or t 45 ggtccctcct gaacctgtct gcatccattc ccatttcttc ttccgtatgc atgttcccac 60 cgtctaaaaa acctagcaaa gcaacaaaac ggcgtcatgc ttgggaagta gcatgcaatg 120 gtaaccctag aaataggagg gacattctga tcggccttgg aggactctat ggtgctacaa 180 caagtctcac aagtaacaac actggttctg catttggtgc ttcattgtcg cctccagatc 240 caactaactg cgttcaaccg gacccagaaa aagacccttt ttgcccacca cccccttcaa 300 agactacgag ctccctccac acgatgacaa gacattaccc cttcgaatta gaccaagctg 360 ctcatttggt cactgatgat tacatagcca agtacgagga agccgtgagg cgcatgcaag 420 accttccacc tgatgatcct cgcagtttca tgcaacaagc caatgtccac cgtgcctact 480 gcgatggtcc cggctatatc aaaagggttc gctgactaca agcttgacgt tcacggtcct 540 ggatatcctt ccctgggacg ctggtactcc atttctaana aaaacctggg aagatgatcg 600 atgacccact tcgctctncg ttttggaacg ggacaatccc gccggatgag atcctcccat 660 ttcacaagac aaattcactc tctacgacga acacaagaat acgttaatgt taa 713 46 162 PRT Glycine max 46 Ser Leu Leu Asn Leu Ser Ala Ser Ile Pro Ile Ser Ser Ser Val Cys 1 5 10 15 Met Phe Pro Pro Ser Lys Lys Pro Ser Lys Ala Thr Lys Arg Arg His 20 25 30 Ala Trp Glu Val Ala Cys Asn Gly Asn Pro Arg Asn Arg Arg Asp Ile 35 40 45 Leu Ile Gly Leu Gly Gly Leu Tyr Gly Ala Thr Thr Ser Leu Thr Ser 50 55 60 Asn Asn Thr Gly Ser Ala Phe Gly Ala Ser Leu Ser Pro Pro Asp Pro 65 70 75 80 Thr Asn Cys Val Gln Pro Asp Pro Glu Lys Asp Pro Phe Cys Pro Pro 85 90 95 Pro Pro Ser Lys Thr Thr Ser Ser Leu His Thr Met Thr Arg His Tyr 100 105 110 Pro Phe Glu Leu Asp Gln Ala Ala His Leu Val Thr Asp Asp Tyr Ile 115 120 125 Ala Lys Tyr Glu Glu Ala Val Arg Arg Met Gln Asp Leu Pro Pro Asp 130 135 140 Asp Pro Arg Ser Phe Met Gln Gln Ala Asn Val His Arg Ala Tyr Cys 145 150 155 160 Asp Gly 

What is claimed is:
 1. An isolated polynucleotide comprising: (a) a nucleotide sequence encoding a polypeptide having polyphenol oxidase B activity, wherein the polypeptide has an amino acid sequence of at least 80% sequence identity, based on the Clustal V method of alignment, when compared to SEQ ID NO:20, or (b) a complement of the nucleotide sequence of (a), wherein the complement and the nucleotide sequence consist of the same number of nucleotides and are 100% complementary.
 2. The polynucleotide of claim 1, wherein the amino acid sequence of the polypeptide has at least 85% sequence identity, based on the Clustal V method of alignment, when compared to SEQ ID NO:20.
 3. The polynucleotide of claim 1, wherein the amino acid sequence of the polypeptide has at least 90% sequence identity, based on the Clustal V method of alignment, when compared to SEQ ID NO:20.
 4. The polynucleotide of claim 1, wherein the amino acid sequence of the polypeptide has at least 95% sequence identity, based on the Clustal V method of alignment, when compared to SEQ ID NO:20.
 5. The polynucleotide of claim 1, wherein the amino acid sequence of the polypeptide comprises SEQ ID NO:20.
 6. The polynucleotide of claim 1 wherein the nucleotide sequence comprises SEQ ID NO:19.
 7. A vector comprising the polynucleotide of claim
 1. 8. A recombinant DNA construct comprising the polynucleotide of claim 1 operably linked to at least one regulatory sequence.
 9. A method for transforming a cell, comprising transforming a cell with the polynucleotide of claim
 1. 10. A cell comprising the recombinant DNA construct of claim
 8. 11. A method for production of a polypeptide having polyphenol oxidase B activity comprising the steps of cultivating the cell of claim 10 under conditions that allow for the synthesis of the polypeptide and isolating the polypeptide from the cultivated cells, from the culture medium, or from both the cultivated cells and the culture medium. 